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ABSTRACT
For bacterial typing to be useful, the development, validation and appropriate application of typing
methods must follow uniﬁed criteria. Over a decade ago, ESGEM, the ESCMID (Europen Society for
Clinical Microbiology and Infectious Diseases) Study Group on Epidemiological Markers, produced
guidelines for optimal use and quality assessment of the then most frequently used typing procedures.
We present here an update of these guidelines, taking into account the spectacular increase in the
number and quality of typing methods made available over the past decade. Newer and older,
phenotypic and genotypic methods for typing of all clinically relevant bacterial species are described
according to their principles, advantages and disadvantages. Criteria for their evaluation and
application and the interpretation of their results are proposed. Finally, the issues of reporting,
standardisation, quality assessment and international networks are discussed. It must be emphasised
that typing results can never stand alone and need to be interpreted in the context of all available
epidemiological, clinical and demographical data relating to the infectious disease under investigation.
A strategic effort on the part of all workers in the ﬁeld is thus mandatory to combat emerging infectious
diseases, as is ﬁnancial support from national and international granting bodies and health authorities.
CENTRAL THEME
Bacterial typing methods generate isolate-
speciﬁc molecular ﬁngerprints for
assessment of epidemiological relatedness
INTRODUCTION
The ability to quickly and reliably differentiate
among related bacterial isolates is essential for
epidemiological surveillance, and is an endeav-
our as old as the discipline of bacteriology itself.
Long-standing ‘conventional’ typing methods,
such as bacteriophage typing of Staphylococcus
aureus and Listeria monocytogenes [1,2], serotyping
of Salmonella spp. and Escherichia coli [3,4], or
biochemical typing of Enterobacteriaceae [5],
have historically been important contributors to
our understanding of the natural history and
epidemiology of infections caused by strains
of these clinically relevant bacterial species.
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Similarly, antibiogram typing has for many years
been and, as a matter of fact, still is, in the ﬁeld of
clinical microbiology, a ﬁrst-line method to iden-
tify possible cases of bacterial cross-transmission
in healthcare institutions. These methods for
bacterial phenotyping have a clear purpose in
the conﬁrmation and elucidation of local and
national healthcare-associated outbreaks due to
bacterial strains [1]. However, although still
useful for speciﬁc purposes, they have a number
of practical limitations which render them unsuit-
able for comprehensive studies of bacterial popu-
lation structure and dynamics, and also for the
scientiﬁcally less ambitious, but very critical,
endeavours of infection control and surveillance
[6,7]. Furthermore, most phenotypic methods
have been developed for speciﬁc bacterial species
and are not generally applicable. However,
although it is generally accepted that phenotyp-
ing cannot usually stand alone, in some cases
(e.g., serotyping of salmonellae), it is a very
useful prerequisite. Nevertheless, the develop-
ment, application and quality control of phage
typing and serotyping are labour-intensive and
require skills and methodologies that are difﬁcult
to maintain at levels of quality sufﬁcient to satisfy
the standards of today’s accreditation bodies for
microbiology laboratories. More importantly, any
given phenotype does not always accurately
reﬂect the genotype of a microorganism, and
therefore may not provide a reliable and stable
epidemiological marker. The rate of genetic
exchange within many bacterial species means
that a given phenotype may not always reﬂect
evolutionary history. For example, two isolates
that are identical according to phage typing
might in fact be quite unrelated, and conversely,
two isolates that show quite different phenotypes
for a single marker might in fact be closely
related. For these reasons, phenotyping has been
largely replaced by genotypic or ‘molecular’
typing over the past two decades [8–13]. In
principle, at least, asexual (clonal) reproduction
by binary ﬁssion implies that genotypic markers
should reﬂect evolutionary history and would
therefore be useful in delineating a natural
taxonomy. In practice, the ease with which genes
can be transferred among different lineages
means that the data from multiple markers are
required, and even then there is no guarantee
that a natural taxonomy will present itself
[14]. Polyphasic taxonomy currently uses com-
binations of different phenotypic or genotypic
datasets to deﬁne genera, species and even
taxonomically relevant subspecies [15–18]. At
the same time, however, there are inherently
polymorphic loci present in the genomes of all
bacterial species that enable further subspecies
differentiation. Thus, DNA typing, which essen-
tially comprises the direct or indirect assessment of
subspecies nucleotide sequence motifs and their
variation in both primary structure and number of
copiesper chromosome (see Fig. 1 for a generalised
scheme), can reproducibly reveal conserved aswell
as variable characteristics, both at different taxo-
nomic levels and at levels below species/subspe-
cies, the lowest taxonomic rank with ofﬁcial
standing in nomenclature.
Figure 1. The general features of molecular typing methods. The four boxes show the various molecular concepts
associated with genetic variability. Below these boxes, the typing techniques most suited for the detection of such nucleic
acid changes are indicated. More technical detail can be retrieved from various sections in the text.
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Unfortunately, new molecular typing methods
are often proposed for general use without sufﬁ-
cient prior critical evaluation. For example, they
may not have been standardised, a minimal
number of isolates may have been used for
validation, their agreement with epidemiological
data may not have been assessed, or the suitabil-
ity of a speciﬁc method–microbe combination for
a speciﬁc bacterial taxon may not have been
addressed [19–28]. Finally, basic terminol-
ogy—including fundamental terms such as ‘iso-
late’, ‘strain’, ‘type’ or ‘clone’—is often used
differently by different workers in the ﬁeld of
bacterial epidemiology.
Here, we present an update of the previous
ESGEM guidelines for the correct application
of methods and interpretation of the resulting
data [29]. We endeavour to deﬁne the terminol-
ogy used in microbial typing, distinguish the
major means and purposes of bacterial typing,
provide criteria for evaluation, and outline the
advantages, limitations and unresolved issues
related to the methods currently used. We
intend to increase awareness of the importance
of methodological evaluations and optimisa-
tions, and the appropriate use of control and
reference strains, as well as prudent data inter-
pretation. In short, we aim to deﬁne the pur-
pose and choice of methods, in combination
with interpretation of the results, thereby facil-
itating the development of practical decision
trees. We suggest useful ways for the commu-
nication of typing data in general, and more
speciﬁcally, communication from the laboratory
to the clinic. We include discussions on differ-
ent typing applications and their globalisation,
and, importantly, on quality control. Finally, the
links between practical baterial typing and
phylogeny, population biology and taxonomy
are considered. This position paper has been
developed through interactions with microbiol-
ogists active in the ﬁeld, and aims to propose
genuine and applicable general typing guide-
lines. These guidelines, however, should always
be applied carefully and their consequences
interpreted critically in all instances. The
intended audience includes, among many others,
general and clinical microbiologists, infectious
disease specialists, infection control managers,
higher degree students, research technologists
interested in the molecular epidemiology of
bacteria, decision-makers in the context of
public health, and workers in reference labora-
tories.
DEFINITIONS REGARDING ISOLATE
RELATIONSHIPS
Bacterial typing has acquired its own vocabulary,
in part borrowed from that of other scientiﬁc
disciplines, including population biology, molec-
ular biology, taxonomy and ecology. Use of this
terminology is not always consistent and can be
confusing. Prior to presentation of a glossary, we
would like to discuss the terms ‘isolate’, ‘strain’
and ‘clone’ in detail, in order to highlight some of
the debatable issues concerning deﬁnitions, and
thereby suggest a more standardised and uniform
terminology.
The terms ‘isolate’ and ‘strain’ are often used
interchangeably, but not always appropriately. A
bacterial isolate can be deﬁned simply as a single
isolation in pure culture from a clinical speci-
men. Depending on the state of characterisation,
an isolate may be referred to as, for example,
‘urine isolate X’ (if only the sample type is
known) or ‘MRSA isolate Y’ (if the species and
some antimicrobial resistance properties are
known). Ultimately, isolates can be characterised
as descendants of the same strain. However,
there is no agreement concerning the minimal
sets of characters required to deﬁne any kind of
strain. A reference strain is a well-characterised
strain that is maintained in pure culture for
further study, while a type strain is a special
kind of reference strain, i.e., the strain with
which the name of the species is permanently
associated. An isolate can be assigned to a
deﬁned type according to the results of the
application of a particular typing method, e.g.,
pulsed-ﬁeld gel electrophoresis (PFGE) type X,
spa type Y. It must be noted that isolates with
identical typing results need not necessarily
belong to the same strain, since different strains
may be indistinguishable with respect to a
typing method. The opposite can also be true;
isolates with different types may be part of the
same (pandemic) strain. This can be observed
when the intrinsic evolutionary clockspeed of a
given species is higher than average. At present,
different nomenclatures for bacterial strains,
isolates and types exist and these must be
considered with care and used appropriately.
To ensure the consistent use of the terms ‘isolate’
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and ‘strain’, we suggest the following example:
two isolates (1 and 2) can be representatives of
one strain (A), but two strains (A and B) can
never be the same isolate (1).
The terms ‘strain’ and ‘clone’ are also used
interchangeably. The ‘clone’ concept, which is
frequently used in the context of bacterial epi-
demiology and population genetics, also illus-
trates the importance of correct usage of
deﬁnitions and nomenclature. ‘Clone’ is a term
coined in the early 20th century in the ﬁeld of
botany and used to denote a group of isolates
descended from a common ancestor as part of a
usually direct chain of replication [30,31]. The
clonal relatedness of isolates is manifested by
their display of a signiﬁcantly higher level of
similarity in their genotype and/or phenotype
than can be expected for randomly occurring
and epidemiologically unrelated isolates of the
same species. This epidemiological working def-
inition is less stringent than the deﬁnitions of a
clone used by microbial geneticists [31–35]. The
interest in clones has increased over the past
decades, due to the emergence of multiresistant
or highly virulent clones of pathogenic bacteria
that have become widespread and seem to
remain stable for prolonged periods [24–26,33–
38]. Ørskov and Ørskov [31] proposed the
following formulation: ‘The word clone will be
used to denote bacterial cultures isolated inde-
pendently from different sources, in different
locations, and perhaps at different times, but still
showing so many identical phenotypic and
genotypic traits that the most likely explanation
of this identity is a common origin.’ The opposite
of clonality is called panmixis, reﬂecting free
DNA recombination among isolates [35,39,40].
Examples of panmictic bacterial species are
Helicobacter pylori [41] and Neisseria meningitidis
[42]. Isolates of panmictic bacterial species tend
to display extensive genetic variability, and the
molecular ﬁngerprints of a single strain may
vary within a limited number of generations.
Since the terms ‘isolate’, ‘strain’, ‘type’ and
‘clone’ have not always been used according to
the deﬁnitions given above, we propose deﬁni-
tions of a range of terms that are often used by
bacterial typists. We hope that these deﬁnitions
will contribute to consistent usage among
typists and scientists from afﬁliated ﬁelds such
as taxonomy and population genetics and
dynamics.
GLOSSARY OF TERMS
Some of the general terms deﬁned below have
been previously described in the literature
[29,43,44]. The internet was scanned via the
Google search engine, using the terms as key
words (search period November 2006). These
deﬁnitions may have been adapted slightly to
make them consistent with technological and
philosophical approaches.
Alert organisms: Bacterial species, strains,
types or clones of special epidemiological
signiﬁcance because of their predictable trans-
missibility and potential for causing difﬁcult-
to-treat infections. Identiﬁcation of such an
organism should alert healthcare providers
and trigger additional control measures such
as barrier isolation of colonised or infected
patients. Alert organisms are usually impor-
tant nosocomial pathogens or organisms with
an unusual antibiotic susceptibility proﬁle.
Bacterial epidemiology: The study of the
dissemination of human bacterial pathogens,
including their transmission patterns, risk-
factors for and control of infectious disease in
human populations.
Clonal complex: Agroup of bacterial isolates
showing a high degree of similarity, ideally
based on near-identity of multilocus enzyme
proﬁles and multilocus sequence types. Clonal
complexes are identical to clonal groups.
Clonal reproduction:Mode of, usually, asex-
ual reproduction in which the offspring are
essentially identical to the parent. In bacteria,
clonal reproduction proceeds by binary ﬁssion.
Clone: Bacterial isolates that, although they
may have been cultured independently from
different sources in different locations and
perhaps at different times, still have so many
identical phenotypic and genotypic traits that
the most likely explanation for this identity is a
common origin within a relevant time span.
Cluster analysis: Comparative analysis of
typing data collected for a variety of bacterial
isolates in order to group the organisms
according to their similarity in these data.
Clusters can be identiﬁed by manual (visual)
or computerised methods. The partitioning of
a dataset into subsets (clusters) reveals groups
that share common traits.
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Comparative typing: A typing strategy aim-
ed at assessing relatedness within a set of
isolates without reference to other isolates.
Convergence: Independent evolution along
parallel paths in unrelated lineages that ren-
ders the lineages similar for some trait.
Deﬁnitive (library) typing: Type allocation
of organisms according to an existing typing
scheme aimed at the development of
(exchangeable) databases for long-term retro-
spective and prospective multicentre studies
as well as epidemiological surveillance studies.
Dendrogram: Binary tree illustrating a clus-
ter analysis performed on a number of isolates
for any chosen number of typing data. Each
tree, depending on the cluster algorithm used,
depicts possible relationships between the
isolates included in the analysis. The basis for
the tree is all the pairwise comparisons among
the included isolates.
Endemicity: Constant presence in a com-
munity at a signiﬁcant frequency, typically
restricted to, or peculiar to, a locality or region.
This usually presents as persistent occurrence
of disease in a population with a stable long-
term pattern of incidence around short-term
stochastic ﬂuctuations.
Endemic: Strain present in a given setting
over a longer period than if it were epidemic,
although possibly at a relatively low frequency.
Epidemic: The occurrence of an organism
above the usual endemic level as evidenced by a
larger than expected number of infections. Used
as an adjective, the rapid and extensive spread
by infection and/or colonisation that arewidely
prevalent, i.e., affecting many individuals in an
area or a population at the same time.
Epidemic strain: A strain that is suddenly
present in a given setting with an unexpect-
edly high incidence. (However, it is sometimes
difﬁcult to determine whether increased inci-
dence is due to strain traits, since there may
well be other explanations, e.g., poor hygienic
conditions.)
Evolutionary or phylogenetic tree: A dia-
gram that depicts the hypothetical phylogeny
(evolutionary history) of the taxa under con-
sideration. The points at which lineages split
represent ancestor taxa to the descendant taxa
appearing at the terminal points of the tree.
Fingerprint: A speciﬁc pattern (e.g., DNA
banding pattern) or set of marker scores (e.g.,
absorbance values) displayed by an isolate on
application of one or more typing methods.
These ﬁngerprints may be used for assessment
of epidemiological relatedness among bacterial
isolates.
Fitness: The performance of a bacterial
isolate/strain in a particular environment in
terms of survival and reproductive rates.
Genetic drift: The process of random sam-
pling of alleles for each generation, which is
relatively important in small populations, and
is an alternative evolutionary force for natural
selection, causing allele frequencies to change.
Genetic drift determines the distribution of
alleles in different generations.
Genome: The complete genetic information
of an organism as encoded in its DNA and/or
RNA.
Genotype: Genetic constitution of an organ-
ism as assessed by a molecular method.
Hierarchical clustering: A method that
emphasises how adjacent spatial units with
high or low disease rates might cluster by
ranking the units by disease rate, and then
examining how probable cluster adjacencies
would be compared to random conditions, and
marking off successive clusters wherever low-
probability values occur.
Isolate: A population of bacterial cells in
pure culture derived from a single colony. In
clinical microbiology, isolates are usually
derived from the primary culture of a clinical
specimen obtained from an individual patient.
Lineage: Group of isolates sharing essential
characteristics due to common descent.
Linkage disequilibrium: Non-random re-
assortment of alleles occurring at different loci
due to physical linkage, usually due to lack or
inhibition of recombination; strong in clonal
organisms and absent in freely recombining
populations.
Mutation:Thesimplestmutation (change) ina
DNA or RNA sequence is a point mutation (a
one-nucleotide change); othermutations include
deletion or insertion of one or more nucleotides.
Niche: A unique environment or set of
ecological conditions in which a speciﬁc
(micro)organism occurs and thrives.
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Outbreak: Local, initially small-scale, cluster
of disease generally caused by increased fre-
quency of infection in a distinct population
(may be caused by single epidemic strains or
combinations of different strains).
Panmixis: Situation in which gene exchange
occurs randomly in the population at a high
rate. Isolates of panmictic bacterial species
(e.g., H. pylori and N. gonorrhoeae) tend to
display extensive genetic variability, and abso-
lute ﬁngerprint identity may vary even within
limited numbers of generations.
Pathogenicity: Biological ability to cause
disease.
Pattern analysis: The process of comparing
data patterns generated by one or more typing
methods.
Phenotype: The observable characteristics of
a bacterial isolate/strain. Primary phenotype
markers are the distribution of proteins and
other cell components and the morphology
and behaviour of cells.
Phylogeny: Evolutionary relationships
among members of the same taxon (species,
strains, etc.).
Population: A group of organisms of the
same species inhabiting a given environment.
Population dynamics: The study of factors
affecting the variability of populations of
microorganisms over time and space, includ-
ing the interactions of these factors.
Population genetics: The study of variation
in genes among a group of individual bacterial
strains, including the genetic evolution of
populations.
Selection: A natural process resulting in the
evolution of an organism that is best adapted
to a (selective) environment.
Species: The basic taxonomic category of
bacteria; a named group below the genus level
whose members show a high degree of overall
similarityascomparedwithother,moredistantly
related, strains. There is currently no universally
accepted species deﬁnition in the context of
bacteriology, despite many attempts.
Sporadic: Rare, occurring at unpatterned
irregular moments and localities, disconnected
in space and time; the opposite of epidemic
and endemic.
Strain: The descendants of a single isolation
in pure culture, usually derived from a single
initial colony on a solid growth medium.
A strain may be considered an isolate or group
of isolates that can be distinguished from other
isolates of the same genus and species by
phenotypic and genotypic characteristics. Cul-
tures of a particular microorganism, isolated at
the same time from multiple body sites of a
patient and indistinguishable by typing, also
represent a single strain.
Taxonomy: Theoretical study of organism
classiﬁcation, which involves the sequential,
interrelated activities of allocation of organ-
isms to taxa, their nomenclature and identiﬁ-
cation.
Type: A bacterial isolate may be allocated to
a named type according to an existing typing
scheme. Type designations aim at facilitating
the handling and communication of typing
results, and the development of (exchangeable)
databases for long-term retrospective and pro-
spective multicentre studies, as well as epide-
miological surveillance studies.
Type strain: A strain, maintained in pure
culture, with which the name of the species is
permanently associated. The type strain of a
species is marked by a superscript T at the end
of its identiﬁcation number. The type strain is
simply one of the ﬁrst specimens of a
described species. Unfortunately, many so-
called type strains are in fact atypical species
representatives.
Typing: Phenotypic and/or genetic analysis
of bacterial isolates, below the species/subspe-
cies level, performed in order to generate
strain/clone-speciﬁc ﬁngerprints or datasets
that can be used, for example, to detect or rule
out cross-infections, elucidate bacterial trans-
mission patterns and ﬁnd reservoirs or sources
of infection in humans. ‘Subtyping’, a term
commonly seen in American literature, is often
used as a synonym for typing.
Virulence: The property of an infectious
agent that determines the extent to which an
overt disease is produced in an infected pop-
ulation.
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WHAT IS TYPING AND WHAT ARE
TYPING METHODS?
Pathogenic bacteria replicate and persevere in
ecological niches called reservoirs. Reservoirs
may be humans, including (fellow) patients and
healthcare personnel, animals, plants, water,
food and various niches in the environment.
Transmission of bacteria from any of these
sources may generate clusters of colonisation or
infection among humans. Such clusters are
recognised mostly as outbreaks of infectious
diseases. When these outbreaks are not con-
trolled, major epidemics (due to unrestricted
further transmission) may arise. Bacterial epide-
miological typing generates isolate-speciﬁc geno-
typic or phenotypic characters that can be used
to elucidate the sources and routes of spread of
bacteria [46,47]. The scope of typing studies may
vary from purely ‘clinical’ (dissemination of
infections from patients, animals or other sources
to non-colonised and uninfected individuals) to
‘environmental’ (the presence or spread of
organisms in inanimate surroundings) or even
‘industrial’ (identiﬁcation of organisms that are
either valuable or a menace to bio-industry).
Typing may also be used to identify emerging
pathogenic strains or clones within a species,
including potential agents of bioterrorism, in
forensic biology and as evidence in medico-legal
cases. A variety of methods have been developed
to generate isolate-speciﬁc ﬁngerprints, for epi-
demiological typing. These methods should facil-
itate the determination of the relatedness among
isolates derived from outbreak situations or
obvious and recent chains of transmission, in
order to support or reject the hypothesis that the
isolates come from a single source.
Typing data should always be considered
within the time-frame and current epidemiolog-
ical context that are being evaluated and from
which bacterial isolates have been obtained. For
example, more variability can be expected
between related isolates when longer time peri-
ods are studied. The main focus of data inter-
pretation in the clinical setting would be to
identify sources, as opposed to reservoirs of
infection or colonisation [48–50]. Thus, typing
data can distinguish between cases linked to an
outbreak of infections and those unrelated cases
due to more complex scenarios. In addition,
markers of biological diversity can also be
relevant to taxonomy, ecology and the study of
pathogenesis.
To put it simply, typing applies distinct labels to
bacterial isolates. These labels facilitate identiﬁca-
tion of transmission routes and sources. However,
they can also contribute to in-depth investigations
of infectious disease pathogenesis, bacterial pop-
ulation structures and baterial genetics.
Typing can be considered as either comparative
or deﬁnitive (library) typing. In comparative
typing, outbreak-related and unrelated isolates
are compared, since comparison of outbreak-
related isolates with isolates from the past or the
future is not relevant. This is sometimes consid-
ered sufﬁcient for outbreak investigation [20].
However, in many outbreak settings, be they
nosocomial or community-based, it is often useful
to compare strains from a current outbreak with
previous strains, in which case a deﬁnitive
(library) typing method should be used. There-
fore, it is important to set up and maintain
collections of alert organisms in any typing
laboratory. Library systems are those that can be
used in different laboratories, by different inves-
tigators at various time intervals, with the aim of
generating high-quality data to be aggregated in a
single database for comparative assessment, in
great detail at any time [51]. It is thus important
that the typing methods are robust and sufﬁ-
ciently standardised to monitor the organisms of
interest. While various multicentre studies aimed
at standardising potential library typing methods
have been undertaken with varying success, there
already exist a number of international networks
incorporating databases compiled on the basis of
molecular typing data.
Typing can be undertaken at different levels,
depending on the situation: locally, at a hospital
or other primary laboratory, for small investiga-
tions; regionally or nationally, in a reference
laboratory, to bear upon wider issues of public
health and surveillance; or internationally
through collaborative networks, to deﬁne or
survey the worldwide dissemination of major
bacterial clones. At each of these levels, different
methods may be applied.
SETTING UP STRAIN COLLECTIONS
FOR TYPING LABORATORIES
The initiation andmaintenance of strain collections
are prerequisites for an epidemiological typing
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study. The collection should comprise strains of the
species of interest: epidemiologically unrelated
strains, sets of strains from outbreaks, and pro-
spective clinical isolates with well-deﬁned inclu-
sion criteria. The number of strains and the
complexity of the collection are dependent upon
the objective(s) of the research. The organisms
should be stored preferably in glycerol broth at
)80Cor freeze-dried according to accepted guide-
lines for strain preservation. Such collections are of
much less value in the absence of a(n) (electronic)
database of relevant clinical, epidemiological and
demographical data concerning the strains at-
tached. Combining typing data with clinical and
demographical data is deemed to be extremely
important in deriving useful conclusions from
infectious diseases surveillance data. The com-
bined data should comprise: strain designation,
eventual other designations, species name, the
original specimen and its origin, date of isolation,
hospital, department, patient code, city, country,
and—for external strains—identity of provider.
Other relevant (optional) data are: antibiogram,
species identiﬁcation method, and possible associ-
ation with an outbreak or otherwise. For strategic
purposes, it is worthwhile to set up integrated
databases linking the hospital information system,
strain collection database and typing result data-
base, using appropriate software, either commer-
cially acquired or developed in-house.
REASONS FOR TYPING
Typing methods are used to study the spread
and population dynamics of bacteria and other
microorganisms in clinical and environmental
settings, at levels ranging from a single host to a
global ecosystem. To date, these methods are
most easily and conveniently applied to haploid
organisms [40], but interest in the use of meth-
ods for typing of diploid organisms, including
parasites, yeasts, fungi and plants, is growing
rapidly [52,53]. Finally, space (ﬂight) microbiol-
ogy and the prevention of bioterrorism are new
ﬁelds in which microbial typing is useful. In
forensic biology, nucleic acid technology is
applied to human materials [54,55]. Interestingly,
human forensics and microbial typing meet
where bacteria can be used to collect criminal
evidence or to scan crime scenes [56]. Finally,
genotypic methods can also be used in microbial
taxonomy.
Surveillance of infectious diseases
Typing methods contribute useful information to
epidemiological surveillance of infectious dis-
eases, deﬁned as a systematic, ongoing process
of data collection, analysis, interpretation, dis-
semination of results, and action taken, aimed at
recording disease trends and designing ways in
which to curb them [48,57–59]. Detection of
clusters of deﬁned pathogens (alert organisms)
with a similar type may constitute an ‘early
warning’ of a potential outbreak. Library typing,
such as serotyping, phage typing, PFGE or mul-
tilocus sequence typing (MLST), is mandatory for
adequate surveillance of infectious diseases (for
examples, see Pitt [20]).
Outbreak investigation
An outbreak can be deﬁned as a temporal
increase in the incidence of infection (or coloni-
sation) by a certain bacterial species, caused by
enhanced transmission of a speciﬁc strain. It has
to be noted that outbreaks can also be caused by
multiple strains. The increased occurrence of a
single strain, therefore, needs to be distinguished
from the fortuitous accumulation of sporadic
cases. Nevertheless, while this holds true for
healthcare-associated infections, it should be kept
in mind that in the case of foodborne infections,
for example, multi-strain outbreaks can also
occur. This situation is one of the many instances
when accurate epidemiological and clinical
descriptions are needed to prepare the design
and corroborate the results of typing.
In this context, typing methods are applied to
generate and test hypotheses. Typing determines
the number of strains causing the increased
incidence and, ultimately, should help identify
the source(s) of contamination and the route of
transmission. Correct application of bacterial typ-
ing will increase the efﬁcacy of control measures
aimed at containing or interrupting the outbreak
[60,61]. Unfortunately, the relevance of typing in
infection control strategies is still under-appreci-
ated. Didactic instructions should, therefore, be
provided to those using typing in relation to
infection control [62–64]. This should lead to an
improved understanding of methodology and a
better overall appreciation of the added value of
epidemiological typing in the clinical setting. Cost
savings can be derived from curbing unnecessary
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investigations or control measures when a sus-
pected outbreak is dismissed as an accumulation
of sporadic cases derived from a single source.
Study of pathogenesis and the course of
infection
We have already brieﬂy mentioned the two major
uses of typing in studying infections affecting
more than one patient. However, typing can also
be used to elucidate the progress of infection in a
single patient, e.g., by differentiating between an
infection from endogenous microﬂora and that
from an exogenous source [65]. When typing is
used to compare groups of strains that are either
virulent or non-virulent, pathogenesis-related
markers can be identiﬁed. Such markers can
ultimately be translated into clinically relevant
diagnostic targets.
Study of bacterial population genetics
Last but not least, some molecular typing systems
may be applied to large numbers of isolates from
various origins in order to determine the intra-
species population structure, and derive phylo-
genetic hypotheses from this structure [33–35,66].
For example, PFGE analysis of the Pseudomonas
aeruginosa genome indicates that the average
genomic pattern similarity of unrelated strains
ranges between 20% and 60% with an average of
35%, whereas clonally derived strains from a
single host cluster at similarity levels above 80%
[66,67]. Similarly, high-resolution genomic ﬁnger-
printing of Acinetobacter has revealed that strains
of the same species cluster at 50% similarity or
more, while the clone and strain delineation levels
are approximately 80% and 90%, respectively
[68–70].
The current typing method of choice for
performing bacterial population genetics studies,
and the one with the soundest biological basis, is
MLST [71]. This sequence-based technique has
been applied to many important pathogens and
has provided valuable information concerning the
evolution and diversiﬁcation of these species. In
particular, these data have provided the means to
estimate how commonly bacterial genomes un-
dergo horizontal gene transfer and the impor-
tance that this process may have for the
emergence of clinically relevant strains with
heightened virulence or drug resistance [72–75].
Technological aspects of the MLST method will be
discussed in more detail in later sections of these
guidelines.
CRITERIA FOR THE EVALUATION
AND VALIDATION OF
TYPING METHODS
Before a typing method may be used in a given
situation, its appropriateness must have been
clearly demonstrated. Every typing method there-
fore needs to be evaluated and validated with
respect to a number of criteria [76–78]. These can
be divided into performance and convenience
criteria. Because different investigations may
depend on different means and have different
requirements, there is no ideal, universally appli-
cable bacterial typing method [8]. Nevertheless,
the increasing need to communicate among labo-
ratories and to exchange outbreak investigation or
surveillance data requires some degree of agree-
ment on common methods. Such standardisation
is, of course, a lengthy and difﬁcult process, but is
gradually being undertaken for the most popular
and dependable typing methods.
Performance criteria
A good typing method should assess a marker
that remains stable during the study period, and
does not vary to a degree that confuses the
epidemiological picture. This marker should be
testable in every isolate, i.e., it should provide
universal typeability of all isolates. It should also
usefully discriminate among isolates, and this
discrimination should be concordant with the
epidemiological picture. Finally, the results of a
good typing method should be reproducible, inde-
pendently of the operator, place and time [79–81].
A high degree of reproducibility will in turn make
the results of the method amenable to inclusion in
databases and analysis by dedicated computer
software.
Stability
This refers to the stability of the markers assessed
by the typing method: a strain’s marker score
should not change rapidly and should correspond
with the strain’s position in the epidemiological
context. For example, the characteristics tested by a
typing method should remain stable for each
isolate after its primary isolation and during
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laboratory storage and subculture. Preferably, the
assessment of stability should also be performed in
an in-vivo system. Although this may not always
be possible, successful examples have been
reported in the literature [92]. Because mutations
and recombination occur at frequencies dependent
upon species, strain and environmental condi-
tions, the stability of the marker(s) tested by each
method should be evaluated for each bacterial
species studied [93,94]. Stability and reproducibil-
ity (see below) are concepts that are sometimes
confused. To test stability, multiple subcultures of
the same isolate, stored over different periods and
under different conditions, have to be processed in
the same run to minimise laboratory-introduced
variations [95]. A marker can also be considered to
be stable if multiple isolates of an epidemic strain
obtained from different patients at different
moments are indistinguishable by typing based
on that particular marker.
Typeability
This refers to a method’s ability to assign a type to
all isolates tested by it. It can be expressed as the
percentage of typeable isolates over the total
number of typed (typeable and non-typeable)
isolates [82–84]. Whereas most of the genotyping
methods can characterise all of the isolates within
a population (100% typeability), typeability can
be low with classic phenotypic methods such as
serotyping, due to the fact that the existing
serotyping schemes do not cover genetic variation
in full.
Discriminatory power
This refers to a method’s ability to assign a
different type to two unrelated strains sampled
randomly from the population of a given species.
It can be expressed as a probability using Simp-
son’s index of diversity [85,86]. Hunter and
Gaston’s modiﬁcation of Simpson’s index of
diversity and ﬁxed conﬁdence intervals are
important parameters used for making a decision
on strain identity or diversity [86]. The formula
used to deﬁne the diversity index or, better,
Simpson’s index of diversity D is:
D ¼ 1 1
NðN 1Þ
XS
J¼1
njðnj  1Þ;
where N is the total number of strains in the
sample population, S is the total number of types
described, and nj is the number of strains
belonging to the jth type. The index should ide-
ally be 1.00 but, in practice, it should be at least in
the order of 0.95 for a typing system to be con-
sidered more or less ‘ideal’. A 5% probability of
error is accepted by most professionals in the
ﬁeld. Calculations of the diversity index should
be accompanied by critical assessment of the
conﬁdence interval, although this is very rarely
done [87]. Typing methods exploring polymor-
phisms at multiple sites of the whole genome are
more likely to be more discriminatory than are
methods exploring variation at a single locus. For
the purpose of calculation, non-typeable strains
can be either excluded or grouped together,
although the latter does not imply that they are of
the same type. In order to avoid overestimating
the discriminatory power of a system, it is best
that all untypeables be assembled into a single
group.
Epidemiological concordance
The results of a typing method should reﬂect,
agree with, and possibly further illuminate the
available epidemiological information about the
cases of colonisation or infection under study.
For example, epidemiologically related isolates
derived from presumably single-strain or single-
clone outbreaks should be assigned to identical or
related types [22,23]. When validating a method,
it is desirable that several sets, e.g., ﬁve or more,
of outbreak-related strains (n = ﬁve to ten isolates
per set) are included in the test population (see
below). Phenotypic methods are usually less
likely to be concordant with epidemiology when,
for example, distinct strains display similar phe-
notypes (due to evolutionary convergence) [96].
Reproducibility
This refers to the ability of a typing method to
assign the same type to an isolate tested on
independent occasions, separated in time and/or
place [88]. The reproducibility of a marker pattern
(or data generation in general) and that of type
assignment (data interpretation) may be different,
and both need to be evaluated. Reproducibility
may be inﬂuenced by many steps in a procedure,
as a result of either the protocol used or the
stringency of its application. Factors to consider
include: the preparation of materials (e.g., varia-
tion in growth conditions, and methods of DNA
extraction), different batches or reagents, or
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reagent variation as a result of local preparation,
different types of equipment, bias in observing
and recording the results, and, ﬁnally, analysis
and interpretation of results. Reproducibility has
both intra-laboratory and inter-laboratory dimen-
sions. Both require standardised protocols and
adequate personnel training to ensure a reliable
method that produces results that are ‘ﬁt for
purpose’ for different organisms in different
settings [89–91].
Test population
An appropriate and well-deﬁned test population
is a prerequisite for evaluating the typeability,
discriminatory power and epidemiological con-
cordance of typing methods. Note that the
nature of such a population is, of course, deﬁned
by the epidemiological context, the species of
organism involved, whether the studies are local,
regional or global, and whether long-term sur-
veillance is required. A large test population of
isolates correctly identiﬁed to the species level
(preferably n > 100) should be assembled to
reﬂect as much as possible the diversity expected
in the species as a whole, or at least in the sub-
population to which the typing method will be
applied [20–23]. It is recommended to cover as
many ecological niches as may be included in
future investigations, such as particular patient
populations (including age category, immune
status, type of hospital and ward, geographical
origin) and relevant environmental reservoirs
(e.g., for zoonoses or foodborne and waterborne
infections). The test population should include
strains that are presumably unrelated epidemio-
logically, on the basis of detailed clinical and
epidemiological data, as well as outbreak-related
isolates. For these reasons, it is important that
hospital epidemiologists invest in prospective
collections of organisms that have given rise to
important healthcare-associated outbreaks. The
test population is distinct from the panels of
control isolates that should be used in many
studies. For example, in outbreak investigations,
the appropriate level of discrimination of the
typing method(s) should be conﬁrmed by com-
paring the outbreak-related strains to a set of
control strains (n = 10–30) from a similar time
period, locality and patient population, but
which are, a priori, not epidemiologically related.
We feel compelled to emphasise that, although
the earlier version of the current guidelines was
published more than 10 years ago, it has not
been adopted very widely. Publications in which
appropriate test populations are analysed in
detail are rare, and the mathematics required to
support the corresponding conclusions are
hardly ever applied.
Convenience criteria
Once the intrinsic value of a method, as well as its
appropriateness for the typing of a speciﬁc spe-
cies, has been established on the basis of the
performance criteria discussed above, another set
of criteria, those related to feasibility or conve-
nience, need to be considered. These are impor-
tant for the selection of an appropriate typing
method, depending on a number of factors, such
as the scale of the investigation, the timeliness
required of the results, and the ﬁnancial and
technical resources available. The following crite-
ria of convenience, therefore, need to be consid-
ered: ﬂexibility, rapidity, accessibility, ease of use,
costs, and suitability for computerised analysis
and storage of results [97]. The portability of
results is being improved continuously, and this
latter criterion is becoming increasingly impor-
tant.
Flexibility (or spectrum)
This reﬂects the range of species that are typeable
with minimal modiﬁcations of the method [98].
The broader the range of bacterial species that can
be studied, the more central the position of the
method in the general typing laboratory will be.
Modern DNA sequence-based methods show
optimal ﬂexibility in the sense that the principle,
as well as the skills and equipment required, are
the same for different species. Nevertheless, these
methods still need to be optimised and validated
for each species of interest; e.g., ampliﬁcation
primers developed for one species are usually not
useful for another.
Rapidity
This refers to the total time required to get from
the bacterial isolates to the ﬁnal typing results.
The highest degree of typing rapidity can be
attained with methods that are applied directly to
clinical materials, the so-called culture-indepen-
dent procedures [99,100]. Ideally, typing should
be performed in ‘real time’; having results avail-
able within a single working day would strongly
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enhance the clinical impact of epidemiological
typing in general medicine.
Accessibility
This depends upon the availability of reagents
and equipment, as well as the skills required for a
given method in a given laboratory.
Ease of use
This encompasses technical simplicity, workload,
suitability for processing large numbers of iso-
lates, and ease of scoring and interpreting the
results.
Cost
This depends on numerous factors. For example,
there is the amount of the initial capital outlay for
the equipment, its depreciation, which will
depend on whether it is out-of-date compared
with newer versions or totally new platforms, the
frequency and care with which it is used, and
ﬁnally, the costs of any modiﬁcations to the room.
The latter could include the additional options of
extra air-conditioning and ﬂoor reinforcement.
The costs of servicing, the price, need for and
ready availability of replacement parts, and the
cost of consumable reagents should also be
considered. Then there are stafﬁng costs, which
will depend on the time required to perform
procedures, the number and grade of personnel
required, their training and requirements for
demonstration of competencies for accreditation
or other purposes. These costs can be offset, for
example, by income generation, which will
depend on the ability to provide typing services
for others or income-generating training courses
for others to learn the typing method.
Amenability to computerised analysis and
incorporation of typing results in electronic databases
These two factors are most important for longi-
tudinal comparison of large numbers of isolates.
At the local (hospital) level, data obtained by
robust typing methods can be analysed elec-
tronically or assessed visually. Visual interpre-
tation, even when only small numbers of
isolates are studied, requires normalisation of
the data prior to inspection [101]. Nevertheless,
since clones are spreading among hospitals or in
the community, both regionally and globally, it
is important that electronic databases be created,
enabling microbiologists and public health insti-
tutes to monitor the spread of such strains or
clones beyond the hospital level. Of course,
computerised analysis is optimal in combination
with library methods of typing, with MLST as
the current key example.
VALIDATION OF NEW METHOD–
MICROBE COMBINATIONS
Application of any typing method requires care-
ful assessment of its suitability for a species not
yet analysed by it. New methods or variants of
existing ones are published on a regular basis
[102], but they vary widely in terms of how well
validated they are. It cannot be emphasised
enough that testing limited numbers of bacterial
isolates without adequate follow-up, using non-
validated technology in merely local applications,
should be discouraged. In the current era, when
complete genome sequences are available for
multiple strains of most, if not all, clinically
relevant microorganisms, such sequence deposi-
tories can generate important clues for the selec-
tion of appropriate molecular typing targets.
Protocols for frequently used typing methods
should be validated according to the recommen-
dations given in this article by networks of expert
laboratories. Subsequently, certiﬁed ‘end-user’
laboratories should attentively adhere to these
protocols. Admittedly, the latter simple statement
is often difﬁcult to translate into practice; the
personal preferences of many scientists can
severely compromise the objective of working
according to a standardised protocol. In conclu-
sion, inter-method validation is important and
necessary, both from a theoretical point of view
and from a practical perspective [103].
PRINCIPLES AND OVERVIEW OF
CURRENT TYPING METHODS
Over the past two decades, a plethora of novel
and often innovative typing methods has been
developed. These range from methods that assess
simple phenotypic traits to DNA sequencing.
Previously, the comparison of phenotypic char-
acters, which involves the comparison of appar-
ent biological features of isolates, was often
abandoned because of the problems with perfor-
mance criteria already mentioned. Instead, meth-
ods involving the comparison of genomic DNA
fragments were adopted. DNA molecules (or
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restriction fragments or ampliﬁed sections there-
of) can be separated on the basis of their molec-
ular size by gel electrophoresis. Such size
comparisons assess differences in the length of
DNA fragments obtained from DNA from differ-
ent bacterial strains. Whether the fragments of
DNA are natural (e.g., plasmids) or generated at
random, by restriction enzymes or after ampliﬁ-
cation of the DNA using enzymatic DNA repli-
cation (PCR), does not matter; size differences,
provided that they are accurately determined, can
be excellent markers of strain differences.
By deﬁnition, the genome of every bacterial
isolate is unique. The mere fact that DNA
polymerases make copying mistakes during rep-
lication suggests that no genome has a 100%
identical counterpart [104]. However, such muta-
tions must be compatible with nature; they must
be neutral or at least in line with existing
structure–function relationships among the corre-
sponding gene products. Hence, bacterial strains
differ with respect to their complete genome
sequence, and DNA sequencing methodologies
can therefore be used to assess similarity of
strains. A challenge for the near future is to
assess which DNA sequences are useful epidemi-
ological markers, a task that is greatly assisted by
whole genome sequencing [105–107].
Since far more detailed reviews exist concern-
ing the technical aspects of typing methods
[50,108], we will restrict ourselves to deﬁning
brieﬂy the common aspects and quality charac-
teristics of the methods, without any claim to
completeness. The diversity and plethora of
methods available to the scientiﬁc community
are such that it is impossible to be comprehensive
in the subsequent sections. Strategic literature
references will be included to facilitate and
stimulate further reading. Important overviews
of typing methods can also be found in several
general textbooks on the practical and theoretical
aspects of bacterial typing.
Phenotypic typing methods
Phenotyping may involve colony morphology,
colour, odour and other macroscopic features,
but most typing methods rely on traits that
require specialised technology in order to be
documented. For example, they may assess,
qualitatively and quantitatively, the ability of
isolates to grow in the presence of speciﬁc
substances (be they metabolites, drugs, bacterial
toxins or bacteriophages) and their expression of
speciﬁc molecules (be they surface antigens or
allelic variants of housekeeping enzymes). All
methods require strict standardisation of experi-
mental conditions, since phenotypes are generally
quite susceptible to changes in environmental
conditions. In a simple statement: phenotyping
results in the grouping of organisms according to
their similarity in characters resulting from the
expression of their genotypes.
Biotyping assesses biochemical characteristics
that are known to vary within a given species.
Typeability is usually excellent. Discriminatory
power is variable and, to optimise it, a large
number of well-selected characteristics, e.g., meta-
bolic reactions, needs to be included in the test
scheme. Stability is dependent on the species and
characteristic under consideration. The methods
are usually technically easy and inexpensive, the
data generated are simple to score and interpret,
and all tests can be performed, even in the
smallest of laboratories, on large numbers of
isolates. If reproducibility is demonstrated, it can
be used as a library typing method [109,110]. For
instance, commercial systems facilitating the mea-
surement of large panels of ‘biotype characteris-
tics’ have been developed. These systems use
versatile redox technologies, enabling the quanti-
ﬁcation of various biochemical reactions by colour
readings [111–114]. The main power of the system
lies in its ability to distinguish among strains
within a species [115,116]. Phenotype reaction
arrays are available and are useful tools in
addition to DNA and proteomic technologies.
The reproducibility of biotyping is organism- and
character-dependent. It is rarely 100%.
Antimicrobial susceptibility testing (antibio-
gram-based typing) can be performed either by
drug diffusion in solid growth media or drug
dilution in liquid media using a variety of
measurement systems. Most clinical microbiology
laboratories perform some sort of antibiogram
typing, since its results are commonly used to
guide chemotherapy. Therefore, this method has
immediate clinical consequences also. Antibio-
gram-based typing can, with appropriate selec-
tion of drugs, be applied to most species.
Discrimination is dependent on the diversity,
stability and relative prevalence of the detect-
able acquired resistance mechanisms in study
isolates. It is also dependent on the number of
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antimicrobials (including antibiotics no longer in
use, such as neomycin, which are adequate for
revealing speciﬁc resistance mechanisms). Testing
for resistance to heavy metals (resistotyping), as
well as to disinfectants and antiseptics, can
provide useful typing information. The utility of
this method can vary according to the stability of
resistance patterns, which can be insufﬁcient for
use as a clonal marker. Some resistance determi-
nants are plasmid-borne and can be readily lost in
the absence of selective conditions; in addition,
resistance expression can be under the control of
complex regulatory systems [23]. Susceptibility
proﬁles expressed as diameters of inhibition
zones combined with cluster analysis can provide
useful typing data as an adjunct to data generated
by other methods [117,118]. There exist large,
international databases built around antibio-
grams, including data on the geographical origin
and clinical nature of the isolates. Although these
are primarily used to estimate incidences of
resistance, they may, of course, also be consulted
for epidemiological queries concerning the spread
of speciﬁc resistance markers [119,120]. It is of
note that similar resistance patterns may be due to
convergent evolution (as is the case with many
extended-spectrum b-lactamase-producing micro-
organisms, for instance), which is a strongly
confounding phenomenon.
Serotyping is traditionally the most important
phenotypic method that has been developed from
the early days of microbiology. It has led to
comprehensive systems for typing of, for exam-
ple, Salmonella and E. coli isolates. Most typing
sera react with surface antigens. These systems
are still widely used in healthcare-associated or
food-associated microbiology laboratories. High-
throughput procedures using deﬁned sets of
polyclonal or monoclonal antibodies have been
made available [121]. Typeability and discrimina-
tion, complicated by cross-reactions, are variable
[8,21,22]. With adequate quality control of both
reagent and method, serotyping can be a repro-
ducible, library typing method of wide applica-
bility. Standardisation of preparation and testing
conditions is important. Discrimination can some-
times be improved by combining serotyping with
SDS-PAGE, resulting in ‘western’ (immuno)blot-
ting [8,23,122]. Some serotyping schemes (e.g., the
one for E. coli [4] or M-protein typing of Strepto-
coccus pyogenes [123]) are now being replaced by
their genotypic equivalents, where variability is
assessed at the level of genes encoding for the
antigens [124,125]. Similarly, restriction analysis
of the ampliﬁed O-antigen gene cluster (‘molec-
ular serotyping’) has proven to be an interesting
alternative for classic serotyping of E. coli and
Shigella isolates [126,127]. Genetic instability
per se, horizontal gene transfer and convergence
due to natural or vaccine-driven herd immunity
intrinsically limit the power of serotyping
methods.
Phage and bacteriocin typing assess the lytic
patterns of test isolates that have been exposed to
a deﬁned set of bacteriophages, or bactericidal
toxins (bacteriocins). These traditional typing
methods are restricted to a limited number of
species for which such agents have been identi-
ﬁed in numbers large enough to provide a useful
degree of discrimination. In addition, when new
bacterial clones are discovered, additional phages
may need to be included in the typing scheme.
Types can change over the longer term, and this
in itself can be a useful characteristic in endemic
situations. Discrimination is therefore variable,
typeability often partial, and reproducibility poor.
The production and continuous quality control of
phages is important, requiring extensive expertise
and time-consuming efforts. However, large
numbers of isolates can be processed readily,
which is not the case with most current DNA
fragment-based typing methods. Interpretation of
results is not easy and requires training and
experience [128,129]. Nowadays, acquisition or
loss of phages, which may play a role in virulence,
can be traced by molecular typing, providing a
modern extension of the role of phage typing
[130].
Phage typing has long been an important tool
with which to study the epidemiology of S. aureus
for example, but today it has lost its position as a
reference typing method.
SDS-PAGE of cellular and extracellular com-
ponents can give rise to highly discriminatory
typing methods, with applications in taxonomy
also [16,131–134]. In the 1980s, these methods
were applied to a variety of organisms, but since
the 1990s they have been largely superseded by
DNA-based methods. Interestingly, the need for
comparative analysis of the complex banding
patterns obtained by protein SDS-PAGE was the
trigger for the development of dedicated com-
puter software that is now successfully applied to
DNA fragment analysis. By protein SDS-PAGE,
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cell envelope fractions obtained by sonication and
stepwise centrifugation, or whole cells, are solu-
bilised in buffer with the denaturing agent SDS
and separated under denaturing conditions by
PAGE. After staining, the gels are digitised and
the images subjected to cluster analysis. If growth
conditions, sample preparation and electrophore-
sis are rigorously standardised, the proﬁles are
reproducible and suited for databases for longi-
tudinal analysis. Protein SDS-PAGE is rather
laborious and requires experience; the advantage
is that reagents and equipment are relatively
inexpensive.
The step from protein SDS-PAGE to lipopoly-
saccharide (LPS) gel electrophoresis is relatively
small, since the samples prepared for protein
analysis can be treated with proteinase K, after
which they can be used for electrophoretic sepa-
ration of LPS molecules, followed by silver stain-
ing to visualise them. ‘Ladder-type’ LPS gel
electrophoresis can be strain-speciﬁc and has
been used for comparative typing, but the method
is not widely used because it is laborious [135–
137].
Multilocus enzyme electrophoresis (MLEE)
identiﬁes electrophoretic variants of a set of
housekeeping enzymes, encoded by different
alleles of the same gene, thus giving rise to small
but detectable variations in protein size and
charge [138]. MLEE has been used as a reference
method for deﬁning the phylogenetic structure of
clonal lineages in bacterial populations [33,34].
Although it is neither a rapid nor a widely
applied system, it has been very important in
shaping the bacterial population biology land-
scape. Its molecular progeny, MLST (see below),
is much more practical and, hence, more widely
used nowadays.
Mass spectrometry (MS) is a technique origi-
nally developed for the identiﬁcation of (primar-
ily organic) molecules of a low molecular weight
in complex mixtures [139]. Nowadays, the tech-
nology can also be used to characterise mixtures
of complex biological macromolecules, through
their speciﬁc degradation products. Matrix-as-
sisted laser desorption ionisation time-of-ﬂight
(MALDI-TOF) MS facilitates the generation of
molecular ﬁngerprints for entire organisms [140–
142]. The method uses intense laser light to
evaporate the biological material, which is subse-
quently subjected to a strong electrical ﬁeld. Small
ions move at high speed and reach a detector
before the larger ones. The signals generated are
recorded and give rise to complex spectra, char-
acteristic for the molecular content of a bacterial
cell. When these spectra are compared using
appropriate computer software, bacterial types
can be distinguished [143,144]. MALDI-TOF MS is
also suited for the analysis of less complex
mixtures of, for instance, DNA molecules [145–
148] (Fig. 2). Other spectroscopic methods, based
on alternative biophysical strategies, can be used
as well. Infrared (IR) or Raman spectroscopy are
two such methods that can be used for isolate
comparison [149–151]. Both use focused illumina-
tion of bacterial biomass and record the emission
spectra generated. The complexity of the spec-
trum reﬂects molecular complexity and, although
not every peak in the spectrum can be assigned to
a submolecular particle, the composite patterns
can allow comparisons to be performed and types
to be assigned. Other spectroscopic and chro-
matographic methods have been commercialised
successfully and can provide useful platforms for
certain formats of bacterial typing. Gas–liquid
chromatography (GLC; the widely used MIDI
system) and Fourier-transform (FT)-IR spectro-
metry/FT-IR microscopy are merely two exam-
ples [145,152].
Other methods based on physics approaches
will certainly be developed over the coming
Figure 2. An example of the use of mass spectrometry for
the detection of sequence variation in PCR products. After
ampliﬁcation of the DNA stretch under investigation, RNA
is transcribed. This is degraded in a sequence-speciﬁc
manner, and the degradation product is separated and
identiﬁed by mass spectrometry. This will result in reliable
sequence determination. Illustration kindly provided by
C. Ho¨nisch (MassCLEAVE; Sequenom, San Diego, USA).
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decade. An interesting innovative example is
provided by optical mapping of DNA molecules.
This method enables one to really visualise DNA
fragments of large size and it can already be used
for bacterial comparison by looking at single
genomic DNA molecules [153]. Another interest-
ing MS approach is the identiﬁcation of genotypes
of bacteria in complex mixtures of clinical sam-
ples using MS and base composition [154,155]. It
is anticipated that the combination of two-dimen-
sional protein (or DNA) separation techniques, in
combination with spectrometric technologies, will
open possibilities of new generations of typing
systems.
Different ‘‘-omics’’ approaches complete the
modern phenotyping spectrum. Proteomics col-
lectively describes the methods used for deci-
phering the protein content of a bacterial cell.
These range from ‘intelligent’ electrophoresis
technologies to high-throughput, automated,
MS-based protein sequencing facilities.
Glycomics analyses the synthesis, precise
molecular features and diversity of polysaccha-
rides, glycans, lipopolysaccharides and other
glyco- and lipid complexes, while metabolomics
encompasses the diverse metabolic activity of
cells. Phenotyping is thus resurfacing with the
advent of systems biology approaches [156].
Genotypic typing methods
Genotypic typing methods assess variation in the
genomes of bacterial isolates with respect to
composition (e.g., presence or absence of plas-
mids), overall structure (e.g., restriction endonu-
clease proﬁles, number and positions of
repetitive elements), or precise nucleotide se-
quence (of one or more genes or intergenic
regions). Basic genetic analysis of the molecular
event(s) (acquisition, multiplication, mutation,
deletion, insertion) associated with pattern var-
iation is the preferred approach to measuring
inter-strain relatedness, but is neither always
required nor generally feasible [13,157]. A wide
variety of genotypic methods has been pre-
sented, of which the most widely used will be
discussed below in a ‘rational-historical’ order.
The increasing availability of bacterial genome
sequences has had, and is still exerting, a great
impact on the evolution of these methods,
by facilitating the choice of successful typing
targets.
Hybridisation-mediated methods.
Direct (and reverse) hybridisation: Direct hy-
bridisation testing of bacterial genomic DNA
(without restriction enzyme treatment) is feasible.
In all methods, the immobilised DNA to be
investigated is probed with DNA molecules that
are selective; some templates are recognised, and
others are not. The technologies employed vary
widely, but the core technology was developed by
Southern and colleagues [158] (hence ‘Southern
hybridisation’). As a recent example, ‘binary’
typing has been developed for S. aureus through
the isolation of DNA probes that are speciﬁc for
some S. aureus strains [159,160]. The method
proved to be reproducible and easy to perform
[161,162]. Similar systems have been developed
for other bacterial species [163,164]. Direct hy-
bridisation tests can also be used to deﬁne the
nature of mobile elements involved in methicillin
resistance or to identify determinants of glyco-
peptide resistance in S. aureus [165–167]. The
same methodology can be used for typing of
DNA ampliﬁed by PCR [168] For instance,
Mycobacterium tuberculosis ‘spoligotyping’ in-
cludes ampliﬁcation of a locus harbouring tan-
dem repeats with some internal sequence
variation. These variants are then identiﬁed by
hybridisation using repeat-speciﬁc DNA probes
[169,170].
Ribotyping is a classic variant of a Southern
hybridisation-mediated assay [171] that estimates
the number of ribosomal gene loci and their
position in the chromosome. It is reproducible
and applicable to (fast-growing) bacteria, but has
a discriminatory power that is usually lower
than that of, for example, PFGE [12,26,172]. Fully
automated robots for ribotyping have been
made available, reducing hands-on time, albeit
at a signiﬁcant price [173,174]. The automated
method has been compared with a variety of
other genotyping methods [175–182] and,
although it was demonstrated to be useful for
various bacterial species, it did not always stand
out as a superior method [183] since its discrim-
inatory power is relatively limited. Nevertheless,
it is robust, and proﬁles can be compared among
laboratories and be used for the generation of
databases; hence, it was adopted for some
pathogens important in food microbiology
[174]. Reproducibility has been documented
experimentally during clinical microbiological
usage [181,184].
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Genome analysis by array hybridisation
Array systems currently represent state-of-the-art
hybridisation-mediated testing. This method ca-
pitalises on the technological possibility of immo-
bilising up to several hundred thousands of DNA
probes per square centimetre of a solid matrix.
For most of the clinically relevant microorgan-
isms, whole genome arrays have been developed,
based on the available whole genome sequences,
and covering all of the genes identiﬁed. Probes
may be PCR products of deﬁned length, but
synthetic oligonucleotides are more frequently
used. These platforms facilitate bacterial typing in
unprecedented detail. As the method is not yet
suited for day-to-day clinical application, careful
consideration of target genes is necessary in order
to achieve optimal epidemiological concordance.
Currently, costs and accessibility also remain
problematic. A recent comparison of multiple
genomes of strains of the same species has shown
that considerable gene variation exists within a
species, and the term ‘pan genome’ was coined to
denote the cumulative genome deduced from the
individual genome sequences [185]. Hence, it is
emphasised that analyses based on single-strain
genomes of a given species are not likely to be
sufﬁcient to make generalisations about the spe-
cies as a whole.
Fragment-based methods
Plasmid typing assesses the number size and/or
restriction endonuclease digestion proﬁles, after
agarose gel electrophoresis, of these bacterial
extrachromosomal genetic elements. It has been
used for typing of many bacterial species [9].
Typeability and discrimination are variable,
depending on the bacterial species [9]. However,
the lack of stability of plasmid content rendered it
unsuitable for use as a reliable clonal marker in
some studies [186]. It is best combined with other
genomic typing methods, to distinguish, for
example, between spread of a resistant clone
and that of a resistance plasmid [23]. Plasmid
typing is still used frequently in combination with
testing of antimicrobial susceptibility in modern
clinical microbiology laboratories [187,188] to
assess whether an antibiotic resistance gene is
plasmid-borne and can be transferred.
Among restriction fragment length polymor-
phism (RFLP) methods, restriction endonuclease
analysis (REA) was the ﬁrst to be widely used.
The chromosome is digested by frequently cutting
restriction enzymes into several hundreds of
small fragments, which are separated by horizon-
tal gel electrophoresis into complex patterns [10].
It is rapid and, under standardised conditions,
very reproducible and discriminatory. However,
the complex patterns produced complicate inter-
pretation and hinder data exchange among labo-
ratories. In order to simplify the interpretation of
REA results, Southern blot and hybridisation
steps were added. A variant, which is very
important historically, is ribotyping (mentioned
above), a method that couples genome digestion
by a ‘frequent-cutting’ restriction endonuclease
with a 4-bp recognition sequence, and hybridisa-
tion with a probe complementary to rDNA. Some
of the hybridisation probes used are restricted to a
single species; the most illustrious and popular
example is IS6110typing of M. tuberculosis [25].
This method has been the agreed standard among
tuberculosis reference laboratories worldwide
over the past 15 years. It has been applied during
hundreds of studies, and its output has been
shown to be communicable among institutions
and over the years, as thousands of proﬁles
generated in different laboratories have been
integrated in a central database [79,189,190].
A new electrophoresis technique, PFGE, made
it possible to separate large DNA fragments in
agarose gels by periodic alternation of the angle of
the electric ﬁeld’s direction. These DNA ‘mac-
rorestriction’ fragments are generated with
restriction endonucleases with six or more base
pair recognition sites (‘rare cutters’), usually
yielding fewer than 30 large fragments, normally
ranging in size between 20 and 600 kbp. PFGE
was originally used for electrophoretic separation
of the chromosomes of lower eukaryotes [191],
and has enabled epidemiological studies of yeasts
and fungi [192,193]. Only in the case of excessive
endogenous endonuclease or DNA methylation
activities has PFGE been problematic [194]. How-
ever, even these technical problems can be over-
come by the use of chemical endonuclease
inhibitors and alternative restriction endonucleas-
es. PFGE has remarkable discriminatory power
and reproducibility, and has therefore become a
widely applicable method for comparative typing
of almost all bacterial species [8,11,195,196]. With
careful standardisation, acceptable levels of inter-
laboratory reproducibility can be achieved, which
have allowed the creation and maintenance of
international databases, with the PulseNet effort
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representing an important achievement (see also
later sections) [28,197–204]. However, 2–4 days
are required to obtain results and relatively
expensive PFGE equipment is required. Gels need
to be analysed closely and carefully, even after
digitalisation and computerised processing [205].
To conﬁrm the outcome of the mathematical
analysis and to verify, establish or refute ﬁner
discrimination, quality control is essential (see
also the later section on PFGE data interpretation).
PCR ﬁngerprinting relies on the ampliﬁcation
of genomic fragments ﬂanked by one or two
oligonucleotide sequences used as primers.
These primers should preferably be cognate to
the species being typed (e.g., BOX for S. pneu-
moniae [206] or IS256 for S. aureus [207]). Cognate
primers allow for relatively high annealing tem-
peratures, thus contributing to high reproduc-
ibility, in contrast to non-cognate primers such
as the very widely used ‘arbitrary’, random-
sequence primers that range between six and ten
nucleotides in length. Primer pairs are often
designed to be directed outwards from repetitive
elements, to amplify short spacer sequences
lying between these elements. It is a quasi-
universal typing method, exhibiting an easily
adjustable level of discrimination [13,208]. Its
major advantages include ﬂexibility, technical
simplicity, wide availability of equipment and
reagents, and rapid, same-day turnover. How-
ever, interpretation of band differences, of neces-
sity, remains biologically unfounded (it can
never be known, for example, if other unob-
served ‘spacer sequences’ existed that were
longer than what could be ampliﬁed by the
DNA polymerase used) and, as suggested, this
method can rarely be considered a ‘library’
method. PCR ‘ﬁngerprinting’ data, in general,
are considered to be non-exchangeable among
laboratories [27,195,209,210], although commer-
cial tests claim the contrary [211]. In order to
increase the resolution of PCR ﬁngerprinting, an
RFLP step is sometimes added. One example of
a PCR-RFLP method is ampliﬁed ribosomal
DNA restriction analysis (ARDRA), which has
been used successfully for species identiﬁcation
of various organisms, including acinetobacters
[43,212], while there are numerous examples of
this methodology for typing of other bacterial
species. Essentially, PCR-RFLP monitors for a
variety of mutations that can occur in restriction
sites and, as such, is a variant method for
detection of single nucleotide polymorphisms
(SNPs) (see later in ‘Sequence-based methods’).
Yet another PCR-based typing method is ampli-
ﬁed fragment length polymorphism (AFLP)
analysis. AFLPTM is the patented name of a
method designed to selectively amplify subsets
of genomic fragments generated with one or two
restriction enzymes, usually a ‘rare’ and a ‘fre-
quent cutter’ [213,214]. After ligation of adapters
to the restriction fragments, selective ampliﬁca-
tion is achieved by the use of primers that
consist of the adapter-derived core sequence,
including the 3¢-part of the restriction half-site,
and an extension of one or more selective bases.
Elongation will only take place if a nucleotide
complementary to the selective base in the
primer sequence is present in the fragment.
Products can be separated in agarose gels [215–
217], but usually one primer is labelled and
fragment separation is obtained using an auto-
matic DNA sequencing instrument with auto-
mated data capture. The digitised and complex
DNA ﬁngerprints are generally highly reproduc-
ible and have been used very successfully for the
high-throughput molecular typing of large num-
bers of bacterial isolates [218,219] (Fig. 3). Essen-
tially, nearly whole genome coverage can be
attained.
For some bacterial species, databases have
been developed and inter-centre reproducibility
assessed [220–222,224]. Recent and, as yet,
unpublished studies have revealed that AFLP
may also suffer from the absence of inter-centre
reproducibility, especially when different elec-
trophoresis platforms are being employed
[220,221,223]. For Acinetobacter spp., as illustrated
in Fig. 4, the method is useful to identify species
[217], clones within Acinetobacter baumannii
[69,118] and epidemic strains [218]. The proﬁles
generated with labelled primers and automated
sequencing equipment are highly complex, and
dedicated software for cluster analysis is there-
fore mandatory (Fig. 4).
Multilocus variable number tandem repeat
(VNTR) analysis (MLVA) is also a PCR-based
typing method that capitalises on the inherent
variability encountered in many regions of repet-
itive DNA. Repetitive DNA is often incorrectly
copied in bacterial species, through slipped
strand mispairing (SSM) [225–227], thus resulting
in shortening or lengthening of the repeat region
due to deletion or insertion of repeat units,
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respectively [226]. This type of DNA variation can
be simply assessed by performing repeat-span-
ning PCRs and determining the length of the PCR
product. In the case of large repeat units, the
analysis system can be simple (e.g., agarose gel
electrophoresis). However, for shorter repeats,
more complex electrophoresis or MS methods are
required. For each repeat locus, a digit can be
assigned, representing the number of repeats
implied (by electrophoresis) or demonstrated (by
sequencing). When assessing the length of the
product, normalisation of the migration distances
is required to guarantee accurate length measure-
ment (Fig. 5). When several repeat loci are anal-
ysed per isolate, several such digits are obtained,
resulting in a multi-digit, speciﬁc strain code
[226]. Dedicated MLVA systems have been
developed for a variety of species [227–236].
When compared with other genotyping meth-
ods, MLVA has, in general, performed well
[229,237,238]. However, few multicentre studies
have been undertaken. Given its techical simplic-
ity, MLVA may have a successful future. The
major drawback is that the evolution of repetitive
DNA may be too rapid, compromising epidemi-
ological concordance. When the mutation fre-
quency in a locus is known and the frequency of
certain alleles in a population is documented, it is
possible to calculate whether two isolates are
identical on the basis of chance. This is not
feasible with other fragment-based methods.
Also, as for all of the methods that rely on the
estimation of molecular size based on standard
curves, the accurate sizing of fragments, even
using ﬂuorescent detection systems, is not a
simple task, as it is mobility dependent on
sequence composition as well as length.
Sequence-based methods
Single-locus sequence typing (SLST) is an
umbrella term for a variety of methods, in which
sequencing of a single genetic locus has been
shown to provide valuable typing results. Anal-
ysing a single locus means that the amount of
DNA to be sequenced is limited, but it is imper-
ative to select gene sequences that are (highly)
variable. The best example of an established,
epidemiologically signiﬁcant SLST scheme is that
of emm typing for S. pyogenes, which is the
‘genotypic descendant’ of M-serotyping, and
relies on DNA sequencing of only 150 nucleo-
tides, coding for the N-terminal end of an isolate’s
M protein [239]. An international database, incor-
porating a query module, ensures the continuing
enrichment of the type repertoire, and already
includes over twice as many types as those
acquired through the previous use of anti-
sera (http://www.cdc.gov/ncidod/biotech/strep/
strepindex.htm). Another more recent example is
that of the S. aureus protein A gene, spa, whose
repeats are variable in number and individual
sequence [239]. This feature formed the basis for
the currently used sequencing system, which has
been further elaborated upon and validated
[240,241] (Fig. 6). The development of dedicated
software and the possibility of determining
sequences rapidly have now led to an automated
system, which is 100% reproducible among dif-
ferent centres [242–244]. In the case of typing
studies performed on the basis of DNA sequences
in hypermutable regions, it should be noted that
generation of variation may exceed the speed of
spread; mutants may arise during an outbreak
and thus falsely suggest that the outbreak has
multiple sources rather than one.
MboI/Csp6I AFLP for Staphylococcus aureus
Figure 3. Example of high-throughput ampliﬁed fragment
length polymorphism analysis for 12 strains of Staphylo-
coccus aureus. For the same set of strains, various selective
primer pairs were employed, the terminal, selective
sequences of which are identiﬁed on top of the lanes.
Courtesy of G. Simons (Pathoﬁnder, Maastricht, The
Netherlands) and H. Witsenboer (Keygene, Wageningen,
The Netherlands).
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MLST is the genotypic descendant of MLEE
(see above) and assesses DNA sequence variation
among the alleles (usually ﬁve to ten) of house-
keeping genes [71]. It has been widely accepted
and constitutes one of the major ‘typing successes’
of the past decade. It is very important to note
that the ‘wet lab’ developments were paralleled
by very important efforts to standardise the
interpretative, free software (e.g., eBURST) and
to make data freely available via the internet [245–
248]. The implications for population genetics and
dynamics may be more signiﬁcant than those for
bacterial epidemiology, since polymorphism in
the slowly evolving genes, which are its targets,
may not be high enough for useful epidemiolog-
ical comparisons. Furthermore, the genes in ques-
tion are unlikely to have any direct relevance to
virulence or drug resistance traits [249–250].
Other methods using non-housekeeping genes,
or using a combination of housekeeping genes
and those under presumed selective pressure,
have since been described (http://www.mlst.net;
http://web.mpiib.berlin-.mpg.de/MLST/; http://
www2.pasteur.fr/-recherche/genopole/PT8/
MLST/). This is currently the proposed method of
the European Working Group for Legionella Infec-
tions (EWGLI) for epidemiological typing of
Legionella pneumophila [87,251]. MLST has indeed
led to many studies analysing bacterial popula-
tion genetics, resulting in the successful identiﬁ-
cation of major sequence types (STs, clones) and
clonal complexes (CCs) of clinical relevance in a
wide variety of species [75,251–254] (Fig. 7). The
results, strings of digits representing different
alleles, are easily and unequivocally exchange-
able, much more so than images of electrophore-
sed DNA fragments, for example. This already
facilitates the development of publicly accessible
databases for comparison of sequence typing
results [255,256]. In combination with novel
sequencing protocols, this method will probably
remain the most popular for bacterial population
geneticists in the years to come [257]. Neverthe-
less, it has practical disadvantages, including
limited accessibility and high cost [258]. The
practical use of MLST in the ﬁeld of clinical
microbiology has to be accessed, as well as
whether it will allow the clinical microbiologist
to draw conclusions about the spread of strains in
a restricted time-frame.
SNP genotyping involves the determination of
the nucleotide base that is present in a given
isolate at deﬁned nucleotide positions known to
be variable within the population. In essence,
MLST is an SNP genotyping method, but it is
applicable only in genetically heterogeneous spe-
cies where many SNPs are located within the gene
Figure 5. Data normalisation of multilocus variable num-
ber tandem repeat analysis (MLVA) data by stratiﬁcation
for two molecular weight markers. Illustration kindly
supplied by P. Franc¸ois (Geneva, Switserland). Note that
the marker-based normalisation ‘ﬂattens’ the picture,
making the data more comprehensible. As can be seen
by the dramatic changes in the proﬁles, internal migration
controls and standardisation are extremely important.
Figure 6. Principles of spa typing of Staphylococcus aureus.
Part of the protein A-encoding gene, containing 24 nucle-
otide repeats, is ampliﬁed and sequenced. Sequencing
reveals the primary structure of the repeat units, which
facilitates identiﬁcation by an r-code. On the basis of the
series of r-codes identiﬁed, a spa type (t-code) can be
deﬁned. On the basis of t-code relatedness, the homology
score among types can be calculated. In the example above,
types t011 and t1254 are more closely related than either of
the two to t567. Courtesy of A. Mellmann, University of
Muenster, Germany.
21
 2007 The Authors
Journal compilation  2007 Clinical Microbiology and Infectious Diseases, CMI, 13 (Suppl. 3), 1–46
portions considered. Strictly speaking, SNP geno-
typing refers to the analysis of nucleotide poly-
morphisms that are rare (e.g., less than one in 300
bases) along the bacterial chromosome, rendering
the direct assessment of the base identity at the
variable position much more efﬁcient than direct
sequencing of the surrounding region. Hence,
SNP genotyping methods are primarily applied to
deﬁne the relationships among isolates of homo-
geneous pathogens such as M. tuberculosis
[259,260], Bacillus anthracis [261], E. coli O157:H7
[262] or Salmonella enterica serotype Typhi [263].
Variable positions that are useful for typing or
phylogenetic analysis must have been discovered
prior to the application of an SNP genotyping
method. Mutation discovery can be achieved by
genome-wide approaches such as shotgun
sequencing of several strains [264] or microarray
hybridisation-based comparative genome
sequencing [262,265]. Polymorphisms can also
be revealed by screening a number of deﬁned
target genes via sequencing, as in MLST-like
approaches or faster approaches such as denatur-
ing High Performance Liquid Chromatography
(dHPLC) [263]. In order to obtain a set of SNPs
that would represent the diversity of a species in
an unbiased manner, it is crucial that mutation
discovery be performed on a set of strains that are
representative of the breadth of diversity and
phylogenetic lineages of that species. Indeed, sets
of SNPs derived from comparison of strains that
are representative of a limited number of lineages
will mostly contain those SNPs that accumulated
during the evolution of these lineages (but will
ignore SNPs that appeared in other lineages), a
phenomenon called ‘discovery bias’ [259,266].
Once a set of SNPs has been selected, a given
bacterial sample can be screened by a variety of
SNP genotyping methods. Direct sequencing of
regions encompassing the SNPs either by Sanger
sequencing or by pyrosequencing is easy to
implement and reliable for determining the base
present at the targeted SNPs [267]. However, as
stated above, this approach is not efﬁcient if the
entire sequenced region contains only one or
several SNPs. SNP genotyping methods, designed
to be applicable to a high number of SNPs and
samples, are currently being developed at a fast
pace, essentially because of the need for high-
throughput SNP genotyping in human diversity
studies and pharmacogenetics. For example, the
method known as ‘mini-sequencing’ involves the
use of a mixture of all four dideoxynucleotides
(without deoxynucleotides) to extend a primer by
a single base. The identity of an SNP can be
determined by using a primer ending just one
base upstream of the SNP. The incorporated base
can be determined by ﬂuorescence after capillary
electrophoresis [252] or by direct measurement of
the mass of the resulting product by MS [268].
Several reviews describe promising SNP geno-
typing approaches [269–273].
Similar to the fact that using the same target
genes in MLST studies allows international stan-
dardisation and comparison of genotyping data
from different users, the use of standard sets of
SNPs for given bacterial species or groups should
facilitate future collaboration.
INTERPRETATION OF TYPING
RESULTS
Theoretically, the ideal method with which to
deﬁne the genetic relatedness of bacterial isolates
Figure 7. The major clonal complexes of Staphylococcus
aureus as deﬁned by multilocus sequence typing (MLST)/
eBURST. The ﬁgure was generated using eBURST on the
whole S. aureus MLST dataset, consisting of 1688 isolates
(832 sequence types (STs)) as of October 2006 (http://
saureus.mlst.net/eburst/). Singleton isolates and minor
clusters were removed, and the remaining clonal com-
plexes (CCs) arranged for clarity. Each circle represents
one ST. The diameter of the circle reﬂects the frequency of
that ST (i.e., the number of isolates). Linked STs differ at
one locus out of the seven (single-locus variants (SLVs)).
For each complex, a ‘founder’ ST is assigned, which is the
most parsimoniously ‘central’ ST (shown in blue). ‘Sub-
group founders’, which are STs from which at least two
SLVs have descended, are shown in yellow. Six major CCs
are named (CC30, CC5, CC8, CC45, CC1, CC15)—in each
case, these names refer to the ST of the founder (e.g., the
blue founder of CC30 is ST30). Other common STs of
clinical relevance are indicated by the red arrows (e.g.,
ST36 consists of EMRSA-16 strains). The arrangement of
the CCs does not reﬂect the relatedness among them.
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at the subspecies level would be complete
genome sequencing [8]. Nevertheless, even when
it originated, the thresholds of epidemiologically
useful discrimination would have to be debated
according to, not only the species, but also the
requirements of each epidemiological study set-
ting. Therefore, several less comprehensive, but
more practical, methods are now used to assess
polymorphism in bacterial genomes, as outlined
above. The data thus generated raise questions
about interpretation, which is often complex.
There are several general issues, however, that
are related to the quantitative analysis of bacterial
genomic polymorphisms obtained for typing. A
number of ways of assigning types, building on
previously published suggestions and the accu-
mulated experience of numerous ‘typists’, are
proposed below.
Interpreting DNA fragment patterns
Isolate relatedness is frequently inferred from
genomic typing methods on the basis of DNA
fragment size after separation by electrophoretic
methods, in terms of either absolute number of
band differences or percentage similarity of
banding patterns. Percentage similarity scores
are generally preferred because they are indepen-
dent of ﬁngerprint complexity, require simple
mathematics and can be generated by dedicated
software programs. In addition, on the basis of
percentage differences, categories of strain
relatedness can be deﬁned in a concise manner.
However, percentage similarity will be inﬂuenced
by the level of tolerance in the differences in
band position chosen for each analysis.
The absolute number of band differences is a
measure that needs to be interpreted with caution;
its weight will be related to the denominator,
which is the number of resolved DNA fragments.
This number is related to inherent intra-species
genome variation rates, the choice and number of
genomic sites probed (itself depending on the
number and nature of restriction enzymes and/or
primers or probes used) and on the ampliﬁcation
and/or separation conditions. Thus, genomic
pattern similarity values must be based on a
sufﬁciently large number of genomic sites/bands
for each isolate. If low-copy-number and variable-
copy-number RFLP probes (e.g., IS sequences) are
used, a composite similarity coefﬁcient must be
constructed by adding the data obtained using
multiple probes. In addition, any inferred mea-
sure of inter-strain relatedness is relative only to
the overall relatedness in that particular sample of
isolates. At any rate, genomic pattern similarity
can in no way be considered as a measure of
genetic distance, because band positions are not
independent, and nor are they evolutionary units.
Nevertheless, in practice, a concise set of simple
rules for interpretation is obviously useful.
Assigning types by interpreting
PFGE-generated patterns
When compared by PFGE, two isolates differing
by one mutational event (from a single nucleotide
substitution to insertions or deletions of longer
DNA sequences) may differ by zero (when the
mutation alters neither a restriction endonuclease
site, nor the size of the resulting fragments—as a
single nucleotide mutation outside the restriction
endonuclease recognition site may do, for exam-
ple) and up to four DNA fragments, or ‘bands’
[274]. When there are no observed band differ-
ences, the isolates should be termed ‘indistin-
guishable’, rather than ‘identical’, and assigned to
the same type (e.g., A) and subtype (e.g., A1) if
other subtypes exist. Such subtypes (e.g., A1, A2,
A3) will be assigned to isolates that differ by one
to four bands (Fig. 8). According to a similar
calculation, ﬁve to eight band differences could be
attributable to at least two mutational events. It
has been proposed that isolates putatively distant
by two mutational events should also be assigned
to subtypes, and that only isolates distant by three
or more mutations (therefore differing by at least
nine bands) should be assigned to distinct types
(e.g., A, B, C) [90,273]. Tenover et al. [90] further-
more suggested that, in the context of habitual
healthcare-associated outbreaks of limited dura-
tion (usually restricted to episodes of half a year
or less), isolates differing by one to four bands be
considered as ‘closely related’ and therefore
‘probably part of the (same) outbreak’. In short-
term outbreak typing, single band differences
should be deemed important. Isolates differing by
ﬁve to eight bands would then be ‘possibly
related’ isolates and therefore ‘possibly part of
the outbreak’. Unfortunately, these suggestions
are often misinterpreted as hard and fast ‘guide-
lines’ and are applied outside the context that the
authors took great pains to delineate. We there-
fore wish to emphasise that epidemiological
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interpretation of differences in PFGE patterns
cannot blindly follow these suggestions.
Examples of possible exceptions and points to
consider follow.
The relative validity of this simple ‘biological
rule’ becomes immediately apparent if one con-
siders that, according to the above, four band
differences may arise from four independent
mutational events, each giving rise to only a
single band difference, while ﬁve band differ-
ences may arise from only two mutational events.
In this case, two isolates with the former relation-
ship would be less ‘related’ than two with the
latter. Once again, only the consideration of
epidemiological data would help to clarify the
issue. On the other hand, even strains differing by
a single band difference may have distinct bio-
logical and epidemiological characteristics. For
example, during an outbreak of S. enterica subsp.
enterica serotype Blockley that lasted for several
months, two PFGE subtypes, named A2 and A4,
differed not only in their resistance to nalidixic
acid, but also in their temporal and geographical
distribution [274]. In this case, the outbreak was
extended, and more band differences may have
been expected. However, it needs to be borne in
mind that the isolates belonged to the same
serotype of the same subspecies of the same
species. Therefore, the inherent diversity of the
study sample was already limited, which makes it
clear that it is, indeed, important to take the
evolutionary mutation rate of a species (if known)
into account.
The following recommendations follow from
the above discussion:
1. Isolates with patterns differing by one to four
bands should be assigned to subtypes of the
same type.
2. Isolates with patterns differing by ﬁve or more
bands should be assigned to distinct types.
3. Inferring the epidemiological relationship of
two or more isolates, according to PFGE types
or subtypes, requires careful thought in every
case, and consideration of the contribution of
other information (clinical, epidemiological
and biological characteristics of the outbreak
and the possibity of invader isolates being
introduced during the outbreak).
The foregoing applies to visual analysis of a
usually limited number of proﬁles. Computer-
assisted cluster analysis based on the similarity of
proﬁles requires the prior decision of a cut-off
similarity level. The similarity of PFGE proﬁles
requires that only positional correspondence is
taken into account; the Dice coefﬁcient is the most
widely used for this purpose. Computer-assisted
cluster analysis is inevitable for the comparison of
large numbers of proﬁles generated at different
moments and—in the case of inter-laboratory
networks—at different locations. A certain ‘simi-
larity threshold’ has to be chosen to deﬁne types in
this situation [67]. An inter-laboratory studywith a
rigorously standardised protocol investigating
outbreak and non-outbreak strains of A. baumannii
showed that strains regarded as being the same
type clustered at 95–100% if processed in the same
laboratory. Central analysis of the data of the same
set of strains generated by the three participating
laboratories showed that strains of the same type
clustered at 87% [28]. Identiﬁcation of similar or
identical strains (types) by band-based pattern
analysis at a similarity level of 80% was also
instrumental in delineating a clone of multidrug-
resistant A. baumannii in Southeast England [276].
Since percentages are usually calculated using
software programs in which parameters (such as
the tolerance of band differences) can be set by the
user, the same patterns may yield different quan-
titative relationships. Furthermore, the user must
always check the software assignations, since, for
example, gel imperfections may be interpreted as
bands by the program. Finally, when two or more
Figure 8. Example of a pulsed-ﬁeld gel electrophoresis
(PFGE) analysis. Lanes marked M display molecular
weight markers, the sizes of which are indicated on the
left. Note that for normalisation purposes, markers are
used every sixth lane. That such precautions are required
is made obvious by the electrophoretic anomalies that can
be observed in lanes 1–3, where the fragments are not
exactly vertically aligned. Red boxes identify indistin-
guishable patterns, whereas the green box identiﬁes a pair
of related patterns differing by two bands, thereby tracing
subtypes. This suggests an insertion deletion event in one
fragment or the presence of extrachromosomal elements
that differ in molecular size. Gel picture provided by D.
Horst-Kreft (Erasmus MC, Rotterdam, The Netherlands).
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gels are compared, imperfect reproducibility of
electrophoretic conditions may lead to, for exam-
ple, systematic band shifts, which again the soft-
ware program might interpret as differences,
while the careful user can see them for what they
are. Conﬁrmation of software groupings according
to the user’s critical eye, and judgement based on
additional information, are therefore essential at
all times. In conclusion, the following recommen-
dations apply to assignment of types using algo-
rithm-generated percentage differences (valid for
all of the ‘band-based’ methods): (i) in the event
that the ‘biological rule’ described above ﬁts the
algorithm-generated grouping, the aforemen-
tioned recommendations apply; (ii) in the contrary
case, i.e., when isolates differing by ﬁve or more
bands cluster together in epidemiologically plau-
sible groups, it is advisable to assign ‘clusters of
similarity’, rather than ‘types’.
As a ﬁnal comment regarding interpretation of
PFGE-generated patterns, it is emphasised that
large studies assessing inherent intra-species
variability would have allowed a more rational
design of rules for the assignment of types.
Unfortunately, such studies have not been under-
taken in large numbers. However, most of the
European national health centres have developed
various typing databases containing hundreds, if
not thousands, of molecular ﬁngerprints. For
example, databases comprising over 1200 differ-
ent ﬁngerprints have been developed for the agent
of whooping cough, Bordetella pertussis [277,278].
Assigning types by interpreting PCR-generated
patterns
Type assignation to PCR-generated band patterns
by visual analysis is even more problematic than
it is with PFGE-generated patterns, since the
biological explanation of band differences is
usually unclear, and at any rate complex. In
addition, it may be tempting to take band inten-
sity into account. Thus, recommendations in this
case would have to be limited to the following:
1. Isolates differing by one or more bands should
be assigned to distinct types.
2. Band intensity should only be taken into
account once it has been demonstrated
unequivocally, by appropriate replicate exper-
iments, that it is reproducible.
However, essentially the same requirements
as those for PFGE apply to the inference of
strain relationships from PCR-generated types
that are based on the comparison of banding
patterns (e.g., AFLP). As discussed, when
assessing MLVA by gel electrophoresis, some
information (e.g., point mutations) may be lost,
in contrast to analysis by DNA sequencing.
MLVA-generated banding patterns should
therefore be interpreted as though they were
PCR-generated.
For computer-assisted pattern analysis of PCR-
and AFLP-generated ﬁngerprints, the Pearson
product moment correlation coefﬁcient is the
most objective and reliable similarity measure. It
(i) is independent of relative intensities of patt-
terns; (ii) is largely insensitive to differences in
background; and (iii) does not suffer from
subjective band detection and band-matching
criteria, since it compares the entire proﬁle rather
than speciﬁc band characteristics and relative
band intensities. However, for simple PCR-RFLP-
generated proﬁles, a band-based coefﬁcient such
as Dice is therefore recommended.
Generally, if groups are robust, different sim-
ilarity measures and clustering algorithms may
largely reveal the same grouping patterns.
Analysis of MLVA proﬁles
Analysis of MLVA proﬁles in potential outbreak
situations, as with other methods, is best
informed by detailed population studies that
have been performed previously. These will
indicate the likelihood of a change in repeat
number at a particular locus during the time-
frame of an outbreak. In most situations, isolates
within an outbreak will (or should) have an
identical MLVA proﬁle. However, whether this
proﬁle is common in isolates unrelated to this
outbreak, i.e., the background distribution of the
MLVA proﬁle in the bacterial population as a
whole, is critical information. Also essential,
particularly with respect to microsatellites, is the
fact that alterations in repeat numbers occur so
rapidly that the proﬁle could change during the
course of an outbreak. Although MLVA schemes
have been proposed for many bacterial patho-
gens, the prerequisites listed above have seldom
been met [278–280].
MLVA can be used for population studies of
microorganisms. An approach that is frequently
applied to MLVA proﬁles is an implementation of
the minimum spanning tree, based on the same
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principles as the eBURST algorithm. These ap-
proaches yield maps of predicted relationships
among strains on the basis of single-locus (where
the proﬁle varies at one locus) and dual-locus
(where the proﬁle varies at two loci) variants. If it
can be assumed that variation in repeat number at
a particular repeat locus is stepwise, i.e., an isolate
with six copies of a repeat at a given locus is more
closely related to an isolate comprising ‘ﬁve
repeats’ than one comprising ‘four repeats’, dis-
tance methods that take the repeat number into
account can be applied. However, if this assump-
tion cannot be made, categorical approaches that
consider all allelic numbers as equally distant are
appropriate.
Interpreting differences among DNA sequences
As mentioned previously, MLVA and sequence-
based methods are likely to replace band-based
methods, mainly because of the difﬁculties in
comparing banding pattern proﬁles among lab-
oratories, despite use of common protocols.
Sequence-based methods are certainly more
portable, as the data are comparable regardless
of the platform used to generate them. The only
prerequisite is that the data are of adequate
accuracy. The value of any sequence database is
determined by the quality of the data within it,
and the role of the database curator is therefore
very important. Most major sequence databases,
e.g., MLST.net, require submission of the raw
sequence trace ﬁles from the laboratory when a
new allele type is proposed [281]. A personal
check of the data by the curator, before accept-
ing the submission, will ensure that the appar-
ent new allele type is not due to an error in the
DNA sequence. Although software (e.g., Phred/
Phrap) can assess DNA sequence quality of
individual traces or of contigs [282], most
curators believe that manual curation remains
the reference standard (PulseNet and SalmGene
are the best known representatives of this
category). The L. pneumophila SBT database
[87], accessible via the EWGLI website (http://
www.ewgli.org/), uses a combination of auto-
mated sequence quality checks and manual
curation. If DNA sequences are submitted to a
database in text format, no guarantee of the
quality of the data is given, beyond checking for
ambiguous bases (the presence of non-A, G, T,
C, such as N, R, W, Y), which may indicate that
the original sequence was not optimal. If the
target used for typing is a coding sequence, it
can be conﬁrmed that the open reading frame
involved is not abrogated. As DNA sequencing
is increasingly used in clinical applications,
rigorous checking of the quality control pro-
cesses that curators of such databases adopt is
recommended.
International efforts in standardisation of type
nomenclature and typing protocols
International travel, migration and food com-
merce are the main factors that have contributed
to the worldwide spread of bacterial clones.
Therefore, the need for international databases,
including those with typing information concern-
ing epidemiologically relevant strains, is strong.
Building such databases, in turn, relies upon
standardisation of typing methods, and on regu-
lar quality assessment ring trials for all partici-
pating laboratories, to guarantee consistently
comparable data. Currently, two types of such
databases have been developed. First, there are
international catalogues of prototype strains, e.g.,
MLST.net and the SeqNet.org spa sequence repos-
itory (spaserver.ridom.de). Second, there are the
molecular epidemiology databases. These include
typing data and information concerning the clin-
ical and/or epidemiological features associated
with the isolates analysed (e.g., PulseNet and
SalmGene).
Inter-laboratory ‘ring trials’ are a relatively
recent development, spurred on by the need for
reliable data to be used in international surveil-
lance. Unwillingness on the part of laboratories to
abandon methods that have taken time and effort
to develop and that produce good results hinders
the standardisation of methods. A way forward is
to ﬁrst seek harmonisation rather than standardi-
sation, changing only those aspects of a protocol
that are shown to be critical to intra- or inter-
laboratory reproducibility. An example of this
was the HARMONY project [203], where PFGE
protocols were examined in several laboratories.
DNA preparation methods, for example, were not
found to be an important factor, provided that all
methods produced good-quality DNA. Many
other aspects required direct standardisation,
however. Pulsing conditions were particularly
critical and, by comparing gel results among
laboratories, new electrophoresis conditions that
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produced optimal separation within an accept-
able run time with good inter-laboratory repro-
ducibility were agreed. Several laboratories have
also found the protocol to be ideal for analysing
coagulase-negative staphylococci, thus reducing
the number of mandatory laboratory standard
operating procedures (SOPs).
Several validated databases exist, making it
possible to compare isolates and discover whether
a given proﬁle has been seen before, and in what
context. For MLST, an excellent website exists
(http://pubmlst.org/) with updated databases on
a range of microorganisms. This exempliﬁes the
successful use of a library typing method, where
the sole sequence can be compared to well-
known, validated MLST sequences and a type
can be assigned. The GENE network concentrated
on exploring the use of the RiboPrinter technol-
ogy (http://www.ewi.med.uu.nl/gene/), as used
for database building, as this equipment is highly
standardised in itself. As already mentioned, the
PulseNet USA database was the ﬁrst database
based on PFGE proﬁles of different foodborne
pathogens (http://www.cdc.gov/pulsenet/), and
was followed by similar networks in Canada
(http://www.cdc.gov/pulsenet/participants_
pages/pulsenet_canada.htm), Latin America
(http://www.panalimentos.org/pulsenet/), and
Europe (http://www.pulsenet-europe.org/)
[283]. Recently, a similar initiative was developed
in Japan [284]. Other PFGE networks have been
developed, e.g., SalmGene, encompassing PFGE
proﬁles of Salmonella species (http://www.hpa-
bioinformatics.org.uk/bionumerics/salm_gene/),
HARMONY (http://www.harmony-microbe.net/
index.htm), including a range of typing methods
for S. aureus, with special attention given to
methicillin-resistant S. aureus (MRSA) isolates,
and Listernet, including both PFGE and antibio-
gram proﬁles of L. monocytogenes (http://www.
eurosurveillance.org/em/v10n10/1010-225.asp).
Such databases require an extremely high level of
standardisation, simple protocols, educated pers-
onnel, and continued quality control, to ensure
that the data can be trusted. These are a few
examples of international cooperation in devel-
oping databases for isolate comparison, as other
databases are being developed.
The use of typing has been extremely valuable
in tracing foodborne outbreaks and pointing out
reservoirs; some of the above databases are
excellent examples of this.
TRANSLATING TYPING RESULTS
INTO CLINICALLY USEFUL
INFORMATION AND APPLICATION
FOR INFECTION CONTROL
Translating typing results into clinical practice is
one of the most important endpoints of a typing
exercise. Performing ‘real-time’ typingmaynowbe
feasible in the microbiology laboratory, but once
indistinguishable isolates are identiﬁed, appropri-
ate clinical action must be taken. Prevention of
infection should be the main goal, although in
several settings, even the prevention of colonisa-
tion (and its spread) is important. In the case of anti-
MRSA policies in the northern European countries
with low incidence rates, adequate typing plays an
important role. The results of typing isolates of
(unexpected) MRSA strains should guide the clin-
ical response; for example, in the case of two
genotypically indiscriminate isolates of MRSA
originating from a single ward or department in
Dutch hospitals, the ward or department will be
closed. This implies that affected patients will be
cohorted, all exposed patients and personnel will
be screened for MRSA carriage (and treated when
found to be positive), operations will be resched-
uled or postponed, and a broad variety of hygiene
measures will be implemented. It is obvious that
this strategy of ‘search and destroy ’ is costly, and
typing data need to be timely and accurate. In the
case of closure of intensive care units, false typing
results also have very expensive consequences.
Ongoing quality assessment of method perfor-
mance will ensure that results remain reliable.
Standardised protocols, training of personnel and
detailed inventories of reagents are all absolute
prerequisites.
Reports of typing results represent an important
diagnosticanddidactic tool forclinicians, including
infection control staff and those involved in direct
patient care. They should be written in an immedi-
ately understandable format that both results from,
and fosters, further interdisciplinary collaboration.
These reports have to include typing and other
data concerning isolates, enabling interpretation
of results in the light of epidemiology (Fig. 9).
Typing should serve to identify clusters of
infection in real time. The ﬁrst indication of
identical types should elicit alarm and lead to
clinical action.However, in order to get the best out
of typing, some prerequisites must be met even
before typing is undertaken. A clear working
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hypothesis, or model, must have been formulated,
on the basis of available clinical and epidemiolog-
ical data (e.g., for an outbreak, putative transmis-
sion routes and/or source(s). The hypothesis will
then be tested by typing; it will also guide the
choice of typing method, since different questions
may require answers with different levels of
reproducibility and/or discrimination. For typing
to contribute to infection control, all parties
involved (e.g., clinical and laboratory doctors and
nurses) must be informed of what will be required
of them (from sampling to performing the actual
typing), and what consequences the results will
have for their practice (e.g., in case one or more
Figure 9. An example of a result report. The report starts with a summary of logistic information, and then the hard
laboratory data are shown, usually as gel pictures or plain DNA sequences, followed by a sample identiﬁcation and some
form of data interpretation. This section may be complemented by a tree visualising the interrelatedness among the strains
isolated. Finally, concluding remarks are given and the form is authorised by the laboratory head, either a medical or a
molecular microbiologist.
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personnel are colonised with the outbreak strain).
Similarly, feedback after typing is essential and
must include all those involved, not only to trans-
late the results into practice, but also to guarantee
continued motivation (Fig. 10). One of the most
impressive published descriptions of the beneﬁts,
including ﬁnancial, of molecular typing for infec-
tion control outlined a scheme that relied on two
simple actions [285]: ﬁrst, the introduction of REA
as a typing method in the clinical microbiology
laboratory of a university hospital; and, second,
weekly, 45-minmeetings of everybody involved in
infection control within this hospital. While the
method may not have been everyone’s immediate
ﬁrst choice, the continuing feedback and the clear-
cut aims guaranteed by the weekly meetings made
this schemea success, leading to a 23% reduction in
infection rate, and consequent annual savings of
approximately $2 000 000. Whether this conse-
quence was fully dependent on the typing itself, or
whether increased awareness due to frequent
discussions of infection control also played a
decisive role, is not really important; it is the net
effect that remains important.
To summarise, collaboration at all stages of a
typing exercise, clear aims and working hypoth-
eses before typing is begun, reliable quality-
controlled data and adequate reporting and feed-
back all contribute to the total value of typing in
clinical practice.
TYPING NETWORKS AND QUALITY
CONTROL
A variety of scientiﬁc initiatives have led to the
establishment of typing networks, some of which
have already been mentioned. Several European
scientists have made efforts towards standardisa-
tion of typing technologies through the ESGEM
network (http://www.escmid.org). PFGE has
formed the basis for the development of several
of the international typing networks including the
HARMONY/MRSA effort [203], and, of course,
the PulseNet network, initiated in 1996 [286].
Initially started in the USA, and now including
PulseNet Europe and other international off-
shoots, it developed into one of the major typing
networks in operation worldwide to date. The
initial aim of PulseNet was to develop subtyping
synchronisation for food-related pathogens. It
started off with E. coli O157:H7, several non-
typhoidal Salmonella serotypes, L. monocytogenes
and Shigella [286]. Currently, Campylobacter has
been added to the list, which will expand further
Figure 10. Source tracking for Legionella pneumophila according to EWGLI. In cases where patients are identiﬁed from
remote regions and environmental investigations have been concluded, species will be typed using serogroup-speciﬁc
antibodies. In cases of identical serogroup and monoclonal subgroup, multilocus sequence typing will be used to further
subtype the strains, after which potential epidemiological associations can be derived.
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in the foreseeable future [287]. For most of the
species currently studied, several thousands of
PFGE ﬁngerprints are stored and regularly anal-
ysed in a cumulative fashion. It goes without
saying that PulseNet relies on extensive standardi-
sation in order to enable ﬁngerprint exchange
among centres and centralised computerised anal-
ysis. Standardisation involved the development of
a universal PFGE fragment size marker standard
[288], reﬁnement of the interpretation guidelines
[289] and, of course, the development of robust
experimental protocols [290]. These efforts are also
controlled through annual accreditation of spe-
ciﬁc, named laboratory personnel, rather than
entire laboratories, which has contributed hugely
to the current success of PulseNet.
However, there is currently no single specia-
lised institution that focuses on the development
of typing standards, both for protocols and for
data interpretation. In molecular diagnostics, such
initiatives are far more advanced, and molecular
typists should proﬁt from the experience gained
in this sector. Novel initiatives such as the
external quality control assessment scheme devel-
oped in Belgium [101] are urgently required.
MOLECULAR TYPING STRATEGIES
IN A NUTSHELL
Typing can be useful at different levels: (i)
locally, at hospitals or other health institutions;
(ii) regionally and nationally, in reference lab-
oratories and research centres; and (iii) globally,
through dedicated networks. The choice of
methods and the concurrent quality assessment
depend on the level at which typing is done.
Local typing
Local typing in clinical microbiology laborato-
ries is undertaken mainly to assess whether an
increase in occurrence of particular organisms
is due to the spread of a single strain. Cur-
rently, the most obvious methods for local
typing are PCR ﬁngerprinting and PFGE, and
to a lesser extent AFLP, but it is likely that
sequence-based methods will soon be more
widely applicable at this level too. The choice
of typing method will be guided by conve-
nience criteria and will depend on the most
common healthcare-associated pathogens
(‘alert organisms’) to be studied.
For these species, collections of unrelated
control strains and sets of isolates assumed to
be epidemiologically related, together with
additional data such as antibiogram and bio-
type, should be set up. They will then be used
to assess precise test conditions for each
species to be typed. It is therefore advisable
that standardised protocols and qualiﬁed
advice from specialists in the ﬁeld are sought
at the start. For each typing exercise it is useful
to include at least three to ﬁve unrelated
strains of the same species to conﬁrm discrim-
inatory capacity, as well as a set of related
isolates from a previous conﬁrmed outbreak,
to assess epidemiological concordance.
PCR ﬁngerprinting
The most simple and rapid genotypic method
for local application is PCR ﬁngerprinting.
PCR ampliﬁcation and separation of frag-
ments can be done in 1 or 2 days. For most
organisms, crude DNA can be obtained by
simply boiling a colony in lysis solution.
Every ﬁfth or sixth lane should include a
reference sample for normalisation. This sam-
ple must be carefully selected and should
contain fragments covering the size range of
the fragments in the samples. Proﬁles should,
preferably, be judged visually. Computer-
assisted analysis of PCR proﬁles can also be
done, and for this purpose the Pearson prod-
uct moment correlation coefﬁcient (which
takes into account band intensity) should be
used, and clustering by the unweighted pair-
group method using arithmetic averages (UP-
GMA) is the recommended distance measure.
Alternatively, Ward’s clustering algorithm
could be used. In the case of small numbers
of samples on one gel, visual analysis is
preferable. In case of doubt about inter-isolate
relatedness, highly similar samples should be
re-run in adjacent lanes to assess whether
they are indistinguishable. Choice of primers,
PCR ampliﬁcation and electrophoresis condi-
tions are important and depend on the micro-
organism under investigation. Widely used
primers, such as REP or ERIC, are of entero-
bacterial origin and may not be truly uni-
versal. They are, therefore, not ideally suited
to all species.
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PCR typing is notorious for its susceptibility
to minor variations in experimental conditions
and reagents, and results may differ among
runs, even in one laboratory. Therefore, the
method is only suited for comparison of small
numbers of samples processed simultaneously
and run on one gel. For longitudinal compari-
son, where large numbers of samples have to be
compared over time, thismethod is not suitable.
PFGE
Today, for most organisms, protocols exist that
provide results in 2–3 days. As with PCR
ﬁngerprinting, the protocols, although gener-
ally similar, are organism-dependent. In elec-
trophoresis, the use of reference samples is
essential, as it is for PCR (see above). The
buffers and reagents for lysis of cells in the
agarose blocks, the enzymes used for DNA
digestion, and the electrophoresis conditions
are all important. For several alert organisms,
well-established protocols are available. If a
laboratory is confronted with another organ-
ism for which, so far, no PFGE analysis has
been done, apart from seeking a protocol for a
(closely) related species in the literature,
advice can be sought from specialists in the
ﬁeld. For comparison of a few isolates, visual
analysis of one gel is easy. ‘Fingerprints’ can
also be analysed by computer-assisted cluster
analysis, usually with the band-based Dice
coefﬁcient. For local surveillance, it is feasible
and worthwhile to set up a database of
ﬁngerprints for alert organisms. Every ﬁfth or
sixth lane should include a reference sample
for normalisation. This sample must be care-
fully selected and should contain fragments
covering the size range of the fragments
included in the analysis.
Sequence-based methods
When the appropriate target sequences have
been selected, sequence methods, whether
they target single or multiple loci (SLST and
MLST), are technically simple. After a selective
ampliﬁcation of (part of) the target, the ampli-
ﬁed product is sequenced using commercially
available technology.
Sequenced mixtures are then read using
tools available in the laboratory, which may
vary from ‘old-fashioned’ radioactive slab gels
to high-throughput 96-capillary automated
sequencers. When sequences have been read,
comparative assessment can be undertaken,
again using a variety of software tools.
Sequence-based methods do not need refer-
ence samples, but they do need strict quality
control in the sense that the sequence output
must be compared with the experimental data
for correctness.
Other methods
Implementation and management criteria for
the other methods listed in previous sections of
this article strongly overlap with those listed
above.
THE INTERFACE OF TYPING AND
BASIC SCIENCE
Although the interrelatedness between basic
microbiological science and bacterial typing is not
the main topic of this publication, the association
between the two is too important to be completely
ignored. The study of bacterial pathogenicity and
ecology will continue to proﬁt extensively from
strain comparisons at the phenotypic or genotypic
level. This has already resulted in a wealth of
information on speciﬁc virulence genes, their
variability and epidemiology, and their involve-
ment in the infectious disease process. Anumber of
fundamental science disciplines such as popula-
tion biology interact with typing extensively.
Among others, studies of the spread and diversity
of types and genes in the population, and the
selective pressures exerted on that diversity, have
contributed to the understanding that clonal and
panmictic species exist and thus enriched our
understanding of infectious disease epidemiology.
An important recent development is the adoption
of a systems approach to biological studies
(Fig. 11). The aim of this approach is to generate a
comprehensive picture of not just the activity of a
single gene under a ﬁxed condition, but of complex
interactions amongmultiple genes in an organism,
and within a speciﬁc environment. Finally, on
the technical side, many novel miniature and
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high-throughput technologies have been devel-
oped recently, and thesewill certainly contribute to
typing in the not too distant future [291].
AN EXAMPLE OF THE
INTERRELATEDNESS OF
MOLECULAR TYPING
(Campylobacte r j e jun i
and i t s infec t ious pa tho logy )
The Guillain–Barre´ Syndrome (GBS) is a post-
infectious neuropathy, with the majority of
cases resulting from molecular mimicry be-
tween human gangliosides and C. jejuni lipool-
igosaccharides (LOS). This was initially shown
to be correlated with O-serotypes of C. jejuni
[292,293]. At a later stage, the molecular mim-
icry hypothesis was reﬁned on the basis of
biophysical and serological studies of the cam-
pylobacter LOS (see Koga et al. [294] andMoran
et al. [295] for a review). However, recent
epidemiological studies on the LOS composi-
tion of larger numbers of GBS-associated strains
of C. jejuni deﬁnitely linked speciﬁc LOS genes
to this mimicry phenomenon [296,297]. They
revealed that certain classes of LOS-encoding
gene complexes were clearly associated with
GBS-disease-invoking potential. Bacterial typ-
ing has thus been instrumental in elucidating
the pathogenic process in GBS patients.
A variety of genome sequences has been
determined within the genus Campylobacter,
including two for the species C. jejuni [298]. On
the basis of these genome sequences, an entire
genome array has been developed by different
groups (e.g., [299]). An array based on the
C. jejuni 11168 genome sequence was used to
conﬁrm that the overall genome plasticity
among C. jejuni strains was relatively low
[300]. This approach resulted in the identiﬁca-
tion of several speciﬁc loci in the C. jejuni
genome that showed enhanced evolutionary
mutation rates, rendering them suitable for
epidemiological studies.
Experimental validation of an extended
array (including the RM1221 genome sequence
data) conﬁrmed the results of the previous
study and helped to deﬁne the levels of
reproducibility of this method of comparative
genomics [301]. A US group also developed
Figure 11. A general scheme showing the position of molecular typing technology in today’s microbiology laboratory and
the systems biology laboratory of the future. Pale blue: the classic microbiological core technology. Blue: the recent
possibilities facilitated by the introduction of molecular technology. Yellow: the integrated systems biology approach. Dark
blue: the place of future personalised medical practice. Host-response based diagnosis is indicated where appropriate.
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an array system that was primarily used for
deﬁning transcription proﬁles [302,303].
However, this array could also be used to
identify genes unique to certain C. jejuni
isolates [304]. This establishes further levels
of Campylobacter diversity, and differentially
occurring genes or gene segments can be used
to develop binary typing approaches. A third
array was used to perform extensive phylog-
enomics and to try and associate type with
source of infection [305]. It was demonstrated
that new reservoirs for C. jejuni can still be
identiﬁed and that comparative phylogeneo-
mics is one of the methods of choice when
trying to deﬁne precise population structures.
It has to be emphasised that the array technol-
ogy at the full genome level is not yet suited
for day-to-day clinical application. It is, how-
ever, obvious that the output of array exper-
iments is highly information-dense and can be
used to deﬁne inter-isolate identity at the
highest possible level and that experimental
data will identify novel targets for the
development of more dedicated typing sys-
tems.
CONCLUDING REMARKS AND
PERSPECTIVES
Although typing protocols and networks have
come a long way and are increasingly proving
their value in the context of infection control and
international infectious disease surveillance,
there are several areas where future work would
be beneﬁcial. Analysis of the molecular events
leading to genomic polymorphism in natural
and experimental conditions should be under-
taken to increase the understanding of the
evolutionary mechanisms of bacterial clones as
they spread in human populations [26,157].
Collections of extensively typed bacterial patho-
gens should be assembled and made available
via public culture collections [20,21,306]. Dedi-
cated working groups should cooperate in opti-
mising inter-laboratory standardisation and
ongoing and independent quality control of
genomic typing methods for speciﬁc pathogens
[25]. Nomenclature used within the various
disciplines employing typing technologies
should be standardised as much as possible,
and should be extended into the ﬁeld of viral
typing [307,308], fungal typing [309], typing of
parasites [310], and perhaps even human geno-
typing. Typing technologies should be made
available to those working in areas where
economic constraints currently prevent adequate
implementation. Appropriate training facilities
should be provided where needed and certiﬁca-
tion could be emphasised. In the end, these
initiatives will lead to the establishment of
reference standard protocols amenable to multi-
centre application.
For several organism–method combinations,
this stage has already been reached and several
such combinations are listed in Table 1.
However, there are still many challenges that
lie ahead. Signiﬁcant funding and continuing
support are required to sustain existing libraries
and develop new methods with the objective
of superior and/or more cost-effective
approaches.
We have not discussed the medico-legal impli-
cations of some typing efforts, and nor have we
discussed applications to disease or colonisation
susceptibility of the human host. The linkage of
typing with disease manifestation has been
touched upon only superﬁcially, but surely
deserves our undivided future attention. It is
currently clear that banding pattern-based meth-
ods are in decline and that more transportable,
objective and technically simple sequence-based
typing systems will be employed in the future
and may constitute a new reference standard.
Although valuable information may be lost by
choosing pure sequence-based approaches,
enlarging the number of sequencing targets per
strain will, in the end, generate sufﬁcient
amounts of data to allow conﬁdent deductions
on inter-strain relatedness to be made. Reports
describing the assessment of hundreds of
sequences per organism have been used to
generate a phylogenetic tree [311]. Such reports
show that, on the basis of pure sequence data,
both taxonomically and epidemiologically signif-
icant nucleotide variation can be monitored.
Typing should be staged carefully and, prior to
using typing in the control of infectious disease,
dissemination of a set of practical guidelines
should be considered and put into practice (see
below).
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THE SEVEN PILLARS
OF WISE TYPING
Formulation of test hypotheses
Informed choice of method & control strains
Use of standardised protocols
Careful interpretation of results
Database maintenance
Feedback to all involved
Continuous training and quality assessment
In conclusion, this position paper has endeav-
oured to sketch the current state of affairs in the
ﬁeld of molecular typing of bacteria. In the
process, we have had to make some more or
less bold choices and, although we hope that
these guidelines will contribute to a fruitful
discussion and a rapprochement of all involved
in this thriving ﬁeld, we would like to end by
stating that we should be ready and willing to
face many more challenges in the near future. In
addition, it would be much appreciated if
funding agencies would remain open to support
of the ﬁeld.
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